<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Acta Pharmacol Sin</journal-id><journal-id journal-id-type="iso-abbrev">Acta Pharmacol Sin</journal-id><journal-title-group><journal-title>Acta Pharmacologica Sinica</journal-title></journal-title-group><issn pub-type="ppub">1671-4083</issn><issn pub-type="epub">1745-7254</issn><publisher><publisher-name>Springer Nature Singapore</publisher-name><publisher-loc>Singapore</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40011630</article-id><article-id pub-id-type="pmc">PMC12098701</article-id>
<article-id pub-id-type="publisher-id">1492</article-id><article-id pub-id-type="doi">10.1038/s41401-025-01492-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Gastrodin promotes CNS myelinogenesis and alleviates demyelinating injury by activating the PI3K/AKT/mTOR signaling</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Shi</surname><given-names>Xiao-yu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>He</surname><given-names>Yi-xi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Ge</surname><given-names>Man-yue</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Liu</surname><given-names>Peng</given-names></name><address><email>wuyuechaoge@163.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zheng</surname><given-names>Ping</given-names></name><address><email>pzheng@shmu.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Li</surname><given-names>Zheng-hao</given-names></name><address><email>lzh9451@163.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/013q1eq08</institution-id><institution-id institution-id-type="GRID">grid.8547.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 0125 2443</institution-id><institution>State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, </institution><institution>Fudan University, </institution></institution-wrap>Shanghai, 200030 China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/013q1eq08</institution-id><institution-id institution-id-type="GRID">grid.8547.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 0125 2443</institution-id><institution>Department of Neurology, Zhongshan Hospital, </institution><institution>Fudan University, </institution></institution-wrap>Shanghai, 200030 China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04tavpn47</institution-id><institution-id institution-id-type="GRID">grid.73113.37</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 1660</institution-id><institution>Institute of Neuroscience, MOE Key Laboratory of Molecular Neurobiology, </institution><institution>Naval Medical University, </institution></institution-wrap>Shanghai, 200433 China </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2025</year></pub-date><volume>46</volume><issue>6</issue><fpage>1610</fpage><lpage>1623</lpage><history><date date-type="received"><day>20</day><month>8</month><year>2024</year></date><date date-type="accepted"><day>20</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Demyelination is a common feature of numerous neurological disorders including multiple sclerosis and leukodystrophies. Although myelin can be regenerated spontaneously following injury, this process is often inadequate, potentially resulting in neurodegeneration and exacerbating neurological dysfunction. Several drugs aimed at promoting the differentiation of oligodendrocyte precursor cells (OPCs) have yielded unsatisfactory clinical effects. A recent study has shifted the strategy of pro-OPC differentiation towards enhancing myelinogenesis. In this study we identified the pro-myelinating drug using a zebrafish model. Five traditional Chinese medicine monomers including gastrodin, paeoniflorin, puerarin, salidroside and scutellarin were assessed by bath-application in Tg&#x000a0;(MBP:eGFP-CAAX) transgenic line at 1&#x02013;5 dpf. Among the 5 monomers, only gastrodin exhibited significant pro-myelination activity. We showed that gastrodin (10&#x02009;&#x000b5;M) enhanced myelin sheath formation and oligodendrocyte (OL) maturation without affecting the number of OLs. Gastrodin markedly increased the phosphorylation levels of PI3K, AKT, and mTOR in primary cultured OLs via direct interaction with PI3K. Co-treatment with the PI3K inhibitor LY294002 (5&#x02009;&#x000b5;M) mitigated gastrodin-induced OL maturation. Furthermore, injection of gastrodin (100&#x02009;mg&#x000b7;kg<sup>&#x02212;1</sup>&#x000b7;d<sup>&#x02212;1</sup>, i.p.) effectively facilitated remyelination in a lysophosphatidylcholine-induced demyelinating mouse model and alleviated demyelination in the experimental autoimmune encephalomyelitis mice. These results identify gastrodin as a promising therapeutic agent for demyelinating diseases and highlight the potential of the zebrafish model for screening pro-myelinogenic pharmacotherapy.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>demyelinating diseases</kwd><kwd>myelinogenesis</kwd><kwd>oligodendrocyte</kwd><kwd>gastrodin</kwd><kwd>PI3K/AKT/mTOR</kwd><kwd>Zebrafish</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">In the central nervous system (CNS), myelination by oligodendrocytes (OLs) enables saltatory nerve impulse conduction and provides trophic and metabolic support for neuronal axons [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Abnormal myelination or demyelination results in cognitive and behavioral deficits in neurological diseases, including multiple sclerosis (MS), leukodystrophies, and some other neurodegenerative disorders [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. New OLs can be generated throughout life by oligodendrocyte precursor cells (OPCs). After myelin damage, OPCs are recruited to the demyelinated lesion core and differentiated into mature OLs to generate new myelin sheaths, a repair process referred to as remyelination [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par3">Although remyelination occurs spontaneously following CNS demyelination, this repair process is often insufficient, which is primarily due to the blockade of OPC differentiation and the reduction in myelinogenic capacity of both surviving and newly differentiated OLs at the demyelinating lesions [<xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref>]. Even when OPCs differentiate and regenerate myelin sheaths, the newly formed myelin sheaths are shorter and thinner than normal [<xref ref-type="bibr" rid="CR5">5</xref>]. Therefore, the development of drug screening research to promote OPC differentiation has been encouraged [<xref ref-type="bibr" rid="CR9">9</xref>]. While a few drugs have finally reached phase 2 clinical trials, only clemastine has shown benefits in the treatment of optic neuritis of MS patients [<xref ref-type="bibr" rid="CR10">10</xref>]. In response, a recent study has shifted the strategy of pro-OPC differentiation towards enhancing myelinogenesis [<xref ref-type="bibr" rid="CR6">6</xref>]. A small-molecule epigenetic-silencing-inhibitor was identified to enhance myelin production and ensheathment, highlighting the potential promise of pharmacological intervention for promoting remyelination.</p><p id="Par4">Zebrafish have become a prominent model for investigating myelination in vivo, primarily due to their transparent larval development. Multiple transgenic zebrafish lines and live imaging-based techniques have provided insight into the dynamic biological processes of OL development [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. As the molecular and cellular functions of zebrafish closely resemble those of mammals, they are considered an optimal tool for efficient screening of phenotype-based drugs [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. This in vivo model facilitates the observation of biological processes, especially myelin formation. Particularly, transgenic lines that label myelin sheaths, such as Tg(MBP:eGFP-CAAX) [<xref ref-type="bibr" rid="CR15">15</xref>], provide a valuable tool for screening pro-myelinogenesis drugs.</p><p id="Par5">Traditional Chinese medicine (TCM) monomers are effective single-compound components extracted from Chinese herbal medicine [<xref ref-type="bibr" rid="CR16">16</xref>]. TCM monomer therapies have been widely used in various CNS diseases, including MS, vascular dementia, and Alzheimer&#x02019;s disease [<xref ref-type="bibr" rid="CR17">17</xref>&#x02013;<xref ref-type="bibr" rid="CR20">20</xref>]. Previous studies have suggested that TCM monomers have a protective effect against white matter damage [<xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref>], but whether they could promote myelination remains incompletely understood. Here, we aim to utilize the zebrafish model for screening TCM monomers that are conducive to the treatment of demyelinating diseases.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><sec id="Sec3"><title>Animals</title><p id="Par6">All animal experiments were approved by the Scientific Investigation Board of Naval Medical University, the Fudan University Animal Care and Use Committee and were performed in accordance with the National Institutes of Health&#x02019;s Guide for the Care and Use of Laboratory Animals. C57/BL6 mice and Sprague-Dawley (SD) rats were purchased from Shanghai Jihui Laboratory Animal Co., Ltd. (Shanghai, China), maintained under specific pathogen-free conditions. We anesthetized mice with pentobarbital, and then the whole brains or spinal cords were collected following transcardial perfusion and overnight post-fixation with 4% paraformaldehyde.</p><p id="Par7">Adult zebrafish were husbandry in a recirculating system with a 14:10 light-dark cycle at 28&#x02009;&#x000b1;&#x02009;1&#x02009;&#x000b0;C [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. They were provided with plumpy shrimp two times per day. Freshly fertilized eggs were produced by pairwise mating and raised in dish containing system water. The zebrafish lines used in this study included: wild-type AB line, Tg(MBP:eGFP-CAAX) - Membrane eGFP in MBP<sup>+</sup> cells, Tg(MBP:Gal4) &#x00026; Tg(5&#x000d7;UAS:GFP) - Gal4 specifically expressed in MBP<sup>+</sup> cells, and Tg(Olig2:eGFP) - eGFP in Olig2<sup>+</sup> cells. Tg(MBP:eGFP-CAAX) and Tg(MBP:Gal4) were created by injecting plasmid Sox10:mRFP, MBP:Gal4, MBP:eGFP-CAAX, together with I-SceI enzyme, into one-cell embryos. Tg(5&#x000d7;UAS:GFP) was a gift from Dr Jiu-lin Du (Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China). Tg(Olig2:eGFP) transgenic line was a gift from Dr B Appel (University of Colorado School of Medicine, Aurora, CO, USA).</p></sec><sec id="Sec4"><title>Drug screening</title><p id="Par8">The Tg(MBP:eGFP-CAAX) transgenic line were used for the drug screening. The embryos were mechanically dechorionated at 24&#x02009;h post fertilization and the larvae were randomly divided into control and the drug-treated groups. Subsequently, they were transferred into small petri dishes containing with 10&#x02009;&#x003bc;M gastrodin (HY-N0115, MedChemExpress, Monmouth Junction, NJ, USA), paeoniflorin (P0038, Sigma-Aldrich, St. Louis, MO, USA), puerarin (P5555, Sigma-Aldrich, St. Louis, MO, USA), salidroside (43866, Sigma-Aldrich, St. Louis, MO, USA) and scutellarin (73577, Sigma-Aldrich, St. Louis, MO, USA), and solutions were renewed every day during the imaging period. Metformin (D150959, Sigma-Aldrich, St. Louis, MO, USA) was used as a pro-myelinating positive control. The fluorescence-positive larvae were manually selected at 3 days post-fertilization (dpf). The larvae were immobilized in 1.4% low melting-point agarose on a glass coverslip and were positioned on the microscope stage with anterior to left and dorsal to top.</p></sec><sec id="Sec5"><title>Single oligodendrocyte labeling</title><p id="Par9">Mosaically labeling oligodendrocytes was performed as previously reported [<xref ref-type="bibr" rid="CR26">26</xref>]. Fertilized eggs were microinjected at the one-cell stage with 1 nL solution containing 45&#x02009;ng/&#x003bc;L Sox10:mRFP plasmid DNA, 45&#x02009;ng/&#x003bc;L Sox10:eGFP plasmid DNA, and I-SceI. Zebrafish were screened at 3 dpf for isolated oligodendrocytes. Sox10:mRFP plasmid was a gift from Dr B Appel (University of Colorado School of Medicine).</p></sec><sec id="Sec6"><title>Lysophosphatidylcholine (LPC)-induced demyelinating model</title><p id="Par10">Demyelinated lesions were produced in the corpus callosum white matter of adult mice (8 weeks) as described previously [<xref ref-type="bibr" rid="CR27">27</xref>]. Mice were deeply anaesthetized with 1.5% isoflurane in 30% oxygen. After exposing the skull, a 34-gauge Hamilton syringe was inserted into the following coordinates: 1.0&#x02009;mm anterior and 1.0&#x02009;mm lateral to bregma; 1.9&#x02009;mm depth from the surface of the skull. 1&#x02009;&#x003bc;L of 1% LPC (L4129, Sigma-Aldrich, St. Louis, MO, USA) was injected at 0.25&#x02009;&#x003bc;L/min and the needle was held in position for 5&#x02009;min to reduce backflow. The mean surface of two adjacent slices (&#x003bc;m<sup>2</sup>) was multiplied by 84&#x02009;&#x003bc;m (4-&#x003bc;m-thick slice&#x02009;+&#x02009;80-&#x003bc;m-interslice gap) to calculate the inter-slice volume (&#x003bc;m<sup>3</sup>). The total demyelinated lesion volume (mm<sup>3</sup>) was calculated based on the equation: V&#x02009;=&#x02009;&#x003a3; demyelinated lesion area&#x02009;&#x000d7;&#x02009;thickness of the section.</p></sec><sec id="Sec7"><title>Experimental autoimmune encephalomyelitis (EAE) induction</title><p id="Par11">EAE induction was performed as previously reported [<xref ref-type="bibr" rid="CR28">28</xref>]. Briefly, female C57BL/6 mice (8&#x02013;10 weeks) were subcutaneously immunized with myelin oligodendrocyte glycoprotein peptide 35&#x02013;55 (MOG 35&#x02013;55, GL Biochem, Shanghai, China) in complete Freund&#x02019;s adjuvant containing heat-killed <italic>Mycobacterium tuberculosis</italic> (H37Ra strain; Difco). Pertussis toxin (200&#x02009;ng/mouse; 516561, Sigma-Aldrich, St. Louis, MO, USA) was administered intraperitoneally day 0 and 2 post-immunization. Clinical EAE scores were examined daily in a blind manner on a scale of 0&#x02013;5 as follows: 0, no clinical signs; 1, paralyzed tail; 2, paresis; 3, paraplegia; 4, paraplegia with forelimb weakness or paralysis; and 5, moribund state or death.</p></sec><sec id="Sec8"><title>Drug administration</title><p id="Par12">For the treatment of LPC mice and EAE mice, 200&#x02009;&#x003bc;L of gastrodin (100&#x02009;mg/kg) or vehicle (0.9% NaCl) was injected intraperitoneally daily. The dosage of gastrodin for mice was based on the previous studies [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>].</p></sec><sec id="Sec9"><title>Cell culture</title><p id="Par13">The detailed methods of the primary OPC culture were previously described [<xref ref-type="bibr" rid="CR31">31</xref>]. In brief, OPCs were isolated from the cerebral cortex of newborn SD rats, and subsequently cultured in Dulbecco&#x02019;s modified Eagle&#x02019;s medium (DMEM, Invitrogen, Waltham, MA, USA) containing 10% fetal bovine serum (FBS, Gibco, Waltham, MA, USA). After 8&#x02013;10 days growth, the cultures were shaken for 1&#x02009;h (180&#x02009;rpm, 37&#x02009;&#x000b0;C) to remove the microglia, then were shaken for 14&#x02009;h (200&#x02009;rpm, 37&#x02009;&#x000b0;C) to collect the OPCs. OPCs were cultured in cultured DMEM/F12 medium supplemented with PDGFaa (0.1%), B27 (2%), N2 (1%) and BFGF (0.1%) for proliferation, and cultured in neurobasal medium supplemented with 2% B27 for differentiation. Triiodothyronine 10 ng/mL&#x000a0;(T3, Sigma-Aldrich, St. Louis, MO, USA) was used as a positive control.</p><p id="Par14">The MO3.13 cell line was purchased from Tongwei (Shanghai Tongwei Industry Co., Ltd, Shanghai, China) and cultured as previously reported [<xref ref-type="bibr" rid="CR32">32</xref>]. MO3.13 cells were maintained in DMEM supplemented with 10% FBS. When the cells reached a density of 80%&#x02013;90%, they were trypsinized and seeded into 6-well plates. Differentiation was initiated at 60%&#x02013;70% confluency, with gastrodin treatment simultaneously.</p></sec><sec id="Sec10"><title>Western blot analysis</title><p id="Par15">Total proteins from primary cultured OPCs were extracted using RIPA lysis buffer containing phosphatase and protease inhibitor cocktail on ice. The lysate was centrifuged at 12,000&#x02009;rpm for 10&#x02009;min at 4&#x02009;&#x000b0;C. The supernatant was diluted with 5&#x000d7; loading buffer and boiled at 95&#x02009;&#x000b0;C for 5&#x02009;min. Subsequently, the total proteins were subjected to Western blot analysis and incubated with primary antibodies anti-PI3K (1:1000; sc-376112, Santa Cruz Biotechnology, Dallas, TX, USA), anti-p-PI3K (1:1000; 4228, Cell Signaling Technology, Danvers, MA, USA), anti-AKT (1:1000; 9272, Cell Signal Technology, Danvers, MA, USA), anti-p-AKT (1:1000; 4051 and 4060, Cell Signal Technology, Danvers, MA, USA), anti-mTOR (1:1000; 4517, Cell Signal Technology, Danvers, MA, USA), anti-p-mTOR (1:1000; 5536, Cell Signal Technology, Danvers, MA, USA), anti-AMPK (1:1000; ab80039, Santa Cruz Biotechnology, Dallas, TX, USA), anti-p-AMPK (1:1000; 2535, Cell Signal Technology, Danvers, MA, USA), anti-&#x003b2;-catenin (1:1000; 32572, Abcam, Cambridge, UK), anti-MBP (1:500; MAB382, Sigma-Aldrich, St. Louis, MO, USA) at 4&#x02009;&#x000b0;C overnight. The proteins were visualized and quantified by Image Lab analysis (ODYSSEY CLX, LI-COR Biosciences, Lincoln, NE, USA).</p></sec><sec id="Sec11"><title>Immunofluorescence staining</title><p id="Par16">Tissue sections or cells were fixed with 4% paraformaldehyde (PFA), blocked with 10% normal goat serum, and permeabilized 0.5% Triton X-100 in phosphate-buffered saline (PBS). Primary antibodies anti-MBP (1:50; ab7349, Abcam, Cambridge, UK), anti-Sox10 (1:200; AF2864, R&#x00026;D Systems, Minneapolis, MN, USA), anti-CC1 (1:200; OP80, Sigma-Aldrich, St. Louis, MO, USA), anti-PDGFR&#x003b1; (1:300; AF-307, R&#x00026;D Systems, Minneapolis, MN, USA), anti-Olig2 (1:500; OB-PGP040-01, Oasis Biofarm, Hangzhou, China), anti-Iba1 (1:200; ab48004, Abcam, Cambridge, UK), anti-GFAP (1:200; ab4674, Abcam, Cambridge, UK) were used at 4&#x02009;&#x000b0;C overnight, followed by incubation with Alexa secondary fluorescent antibodies (1:200; Jackson ImmunoResearch, Bar Harbor, ME, USA) for 2&#x02009;h at room temperature. Fluorescence images were captured using fluorescence confocal microscopy (Dragonfly 200, ANDOR, Belfast, Northern Ireland) and quantified using Image-Pro Plus (Media Cybernetics, Rockville, MD, USA).</p></sec><sec id="Sec12"><title>RNA isolation, reverse transcription, and quantitative real-time PCR (qPCR)</title><p id="Par17">Total RNA was extracted using Trizol (Invitrogen, Waltham, MA, USA). Each RNA sample was reverse-transcribed into complementary DNA (cDNA) using the HiScript III All-in-one RT SuperMix (Vazyme Biotech Co., Ltd, Nanjing, China). RT-qPCR was performed on a LightCycler 96 apparatus (Roche, Basel, Switzerland) using the SYBR Green Pro Taq HS Premix (Accurate Biotechnology Co., Ltd, Changsha, China). Gene expression was expressed as quantified the mRNA level normalized to that of a standard housekeeping gene (<italic>&#x003b2;-actin</italic>) using the &#x00394;&#x00394;CT method and each reaction was set up with three replicates. Primer pairs were as follows: for <italic>&#x003b2;-actin</italic>, F: 5&#x02019;-GTCCACCGCAAATGCTTCTA-3&#x02019;; R: 5&#x02019;-TGCTGTCACCTTCACCGTTC-3&#x02019;; for <italic>Mbp</italic>, F: 5&#x02019;-GAGAGCCTGGATGTGATGG-3&#x02019;; R: 5&#x02019;-CTGTGCCTTGGGAGGAAG-3&#x02019;; for <italic>Plp1</italic>, F: 5&#x02019;-GCACCAAGTTCTGATCCC-3&#x02019;; R: 5&#x02019;-TGGCAAAGGCAAAGAGTT-3&#x02019;.</p></sec><sec id="Sec13"><title>5-Bromo-2&#x02019;-deoxyuridine (BrdU) incorporation</title><p id="Par18">As described previously [<xref ref-type="bibr" rid="CR33">33</xref>], for the in vitro experiment, 10&#x02009;&#x003bc;M BrdU (B5002, Sigma-Aldrich, St. Louis, MO, USA) was added to OPC proliferation medium and incubated for 6&#x02009;h; for the in vivo experiment, mice were administered BrdU (100&#x02009;mg/kg) intraperitoneally on a daily basis for a period of 7 days, commencing from 8 days post-lesion (dpl) to 14 dpl. The samples were fixed in 4% PFA and permeabilized with 0.3% Triton X-100, then immersed in 2&#x02009;M HCl at 37&#x02009;&#x000b0;C for 30&#x02009;min and neutralized in 0.1&#x02009;M sodium borate buffer (pH 8.5) for 20&#x02009;min. Finally, the samples were incubated with primary anti-BrdU (1:100; ab6326, Abcam, Cambridge, UK) overnight at 4&#x02009;&#x000b0;C.</p></sec><sec id="Sec14"><title>Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining</title><p id="Par19">TUNEL staining was performed using the TUNEL kit (C1089, Beyotime Biotechnology, Shanghai, China) according to the manufacturer&#x02019;s instruction. OPCs were seeded on the glass slides in differentiation medium for 72&#x02009;h and fixed before conducting TUNEL staining.</p></sec><sec id="Sec15"><title>Luxol Fast blue (LFB) and histological staining</title><p id="Par20">LFB staining was performed to access white matter damage and demyelination [<xref ref-type="bibr" rid="CR33">33</xref>]. Brain and spinal cord sections were incubated in LFB solution (G1030, Servicebio, Wuhan, China) at 65&#x02009;&#x000b0;C for 4&#x02009;h. Excess stain was then removed with distilled water, and the sections were differentiated by placing them in lithium carbonate and cycling in 75% ethanol solution until white matter was distinguished. Finally, the sections were dehydrated with anhydrous ethanol and made&#x000a0;transparent with xylene, and sealed with neutral resin. LFB staining images were acquired in the bright field and the area of demyelinating lesions was calculated using ImageJ. For hematoxylin and eosin (H&#x00026;E) staining, sections were immersed in hydrochloric acid-alcohol for several seconds followed by 1% ammonia water for several seconds, and then placed into Iraqi red dye for 1&#x02013;3&#x02009;min. Finally, the slices were dehydrated with ethanol for 5&#x02009;min and made transparent with xylene for 5&#x02009;min.</p></sec><sec id="Sec16"><title>Molecular docking</title><p id="Par21">Molecular docking was conducted to explore the interaction of gastrodin and phosphatidylinositol 3-kinase (PI3K). The predicted structures of PI3K were generated by Alphafold (DeepMind Technologies, London, UK). The structure of gastrodin was obtained from the PubChem database. The protein was subjected to a series of optimization procedures, including dehydration, hydrogenation, the removal of solvent molecules. AutoDock Tools (The Scripps Research Institute, La Jolla, CA, USA) were applied to prepare and parametrize gastrodin and PI3K. The docking grid documents were generated by AutoGrid of sitemap, and AutoDock Vina (1.2.0) was used for docking simulation [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. PyMOL (Schr&#x000f6;dinger, LLC, New York, NY, USA) software was used to illustrate the PI3K-gastrodin interaction.</p></sec><sec id="Sec17"><title>Molecular dynamic simulation</title><p id="Par22">The stability of the chosen docking model according to molecular docking was further conformed by molecular dynamic simulation using the non-commercial version 2022.1 of the Desmond/Maestro molecular dynamics software (Schr&#x000f6;dinger, LLC, New York, NY, USA) [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. TIP3P water molecules were added to the systems, which were then neutralized by 0.15&#x02009;M NaCl solution. After minimization and relaxation of the system, the production simulation was performed for 100&#x02009;ns in an isothermal-isobaric ensemble at 300&#x02009;K and 1&#x02009;bar. Trajectory coordinates were recorded every 100&#x02009;ps. The molecular dynamics analysis was performed using Simulation Interaction Diagram from Desmond.</p></sec><sec id="Sec18"><title>Cellular thermal shift assay (CETSA)</title><p id="Par23">The CETSA was performed according to the previous studies with a minor modification [<xref ref-type="bibr" rid="CR38">38</xref>]. In brief, OLs were incubated with 10&#x02009;&#x000b5;M gastrodin for 3&#x02009;h following a three-day differentiation period. Subsequently, the cells were trypsinized and distributed into small centrifuge tubes, then they were subjected to a temperature gradient ranging from 39&#x02009;&#x000b0;C to 49&#x02009;&#x000b0;C for 3&#x02009;min using a PCR instrument. The cells were lysed with liquid nitrogen by the freeze-thawing method. The lysate was then centrifuged at 20,000&#x02009;rpm for 15&#x02009;min at 4&#x02009;&#x000b0;C. The supernatant was collected for Western blot analysis.</p></sec><sec id="Sec19"><title>Drug affinity responsive target stability (DARTS)</title><p id="Par24">For the DARTS assay, we followed the methodology described in a previous report [<xref ref-type="bibr" rid="CR39">39</xref>]. The cultured OLs were homogenized using RIPA lysis buffer containing protease and phosphatase inhibitors, followed by centrifugation at 4&#x02009;&#x000b0;C. The supernatant was collected and the protein content was determined using the BCA quantitative kit (P0010, Beyotime Biotechnology, Shanghai, China). The lysis was then incubated with gastrodin for 20&#x02009;min. The Proteinase K (100&#x02009;ng/mL; ST533, Beyotime Biotechnology, Shanghai, China) was then added to each sample for 3&#x02009;min at room temperature, and the reaction was terminated by heating at 98&#x02009;&#x000b0;C for 3&#x02009;min. The samples were then collected for Western blot analysis.</p></sec><sec id="Sec20"><title>Transmission electron microscopy (TEM)</title><p id="Par25">According to the previous studies [<xref ref-type="bibr" rid="CR40">40</xref>], the corpus callosum containing the lesions was dissected after transcardial perfusion and fixed in 2.5% glutaraldehyde at 4&#x02009;&#x000b0;C overnight. Then the sections were immersed in 1% osmium tetroxide for 45&#x02009;min, after which they were dehydrated with a graded ethanol series and propylene oxide. They were then flat-embedded in a mixture of propylene oxide and epoxy resin (1:1) within a mould. Semithin sections of 2.5&#x02009;&#x003bc;m were stained with 1% toluidine blue to find the lesion. Ultrathin sections, 60&#x02009;nm thick, were mounted on copper grids and stained with uranyl acetate and lead citrate for electron microscopy imaging (Hitachi 7100, Hitachi High-Technologies Corporation, Tokyo, Japan).</p></sec><sec id="Sec21"><title>Statistical analyses</title><p id="Par26">The data were analyzed using one-way ANOVA with Tukey <italic>post hoc</italic> test or Dunnett&#x02019;s multiple comparisons for multiple groups, and unpaired Student&#x02019;s <italic>t</italic> test or Mann&#x02013;Whitney U test was used for two groups (details in figure legends). The data are presented as mean&#x02009;&#x000b1;&#x02009;SEM. The value of <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant. All statistical analyses were made using Prism 6 (GraphPad Software, Inc., San Diego, CA, USA) and PASW Statistics 18 (IBM SPSS Statistics, Armonk, NY, USA).</p></sec></sec><sec id="Sec22" sec-type="results"><title>Results</title><sec id="Sec23"><title>Drug screening in zebrafish identifies gastrodin as a pro-myelinating agent</title><p id="Par27">Myelination in zebrafish spinal cord begins at approximately 2.5 days post fertilization (dpf), first ventrally and then dorsally, and myelin sheath is almost stable by 5 dpf [<xref ref-type="bibr" rid="CR11">11</xref>]. Myelin formation can be visualized via Tg(MBP:eGFP-CAAX) transgenic line, in which membrane-tethered eGFP fluorescence intensity is a proxy measure of <italic>Mbp</italic> promoter activation. To identify the pro-myelinating drug, we evaluated five TCM monomers, including gastrodin, paeoniflorin, puerarin, salidroside and scutellarin (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>), by bath-application of Tg(MBP:eGFP-CAAX) line at 1&#x02013;5 dpf (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>). No morphological abnormalities were observed by TCM monomers treatment (Supplementary Fig. S<xref rid="MOESM6" ref-type="media">1a</xref>). Notably, in comparison with the control group, a significant increase in eGFP fluorescence intensity was observed at 5 dpf in the dorsal and ventral tracts of the spinal cord following gastrodin treatment, but not in the other groups (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1c, d</xref>). Subsequently, the effects of concentration gradients of gastrodin on myelination were tested for optimal dosage, and metformin was selected as a positive control drug. Previous studies and our previous report have demonstrated that metformin has a significant pro-myelinating effect [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. The eGFP fluorescence intensity in the dorsal tracts of the spinal cord showed that the administration of both 10&#x02009;&#x000b5;M and 50&#x02009;&#x000b5;M gastrodin resulted in the promotion of myelination, with the more pronounced effect observed at 10&#x02009;&#x000b5;M (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1e, f</xref>). Therefore, these data indicate that gastrodin facilitates myelination in the zebrafish spinal cord during the developmental stage.<fig id="Fig1"><label>Fig. 1</label><caption><title>Drug screening in zebrafish identifies gastrodin as a pro-myelinating agent.</title><p><bold>a</bold> Chemical structure of the TCM monomers (from ChemicalBook). <bold>b</bold> Schematic of drug screen pipeline. <bold>c</bold> Representative images depicting lateral view of the spinal cord in Tg(MBP:eGFP-CAAX) line at 5 dpf. Red box: location of zoomed-in example region (around 8&#x02013;11 somites). <bold>d</bold> Mean fluorescence intensity of eGFP fluorescent intensity in the dorsal (above) and ventral (below) tracts of the spinal cord (<italic>n</italic>&#x02009;=&#x02009;19&#x02013;23 zebrafish). <bold>e</bold> Representative images depicting the dorsal tracts of the spinal cord in Tg(MBP:eGFP-CAAX) line at 5 dpf. Metformin serves as positive controls. <bold>f</bold> Mean fluorescence intensity of eGFP fluorescent intensity in the dorsal tracts of the spinal cord (<italic>n</italic>&#x02009;=&#x02009;20 zebrafish). Data are represented as mean&#x02009;&#x000b1;&#x02009;SEM, One-way ANOVA and Dunnett-<italic>t</italic> in <bold>d</bold> and <bold>f</bold>.</p></caption><graphic xlink:href="41401_2025_1492_Fig1_HTML" id="d33e531"/></fig></p></sec><sec id="Sec24"><title>Gastrodin promotes myelination by increasing myelin sheath formation</title><p id="Par28">Oligodendroglial development is involved in the process of OPC migration, proliferation, differentiation, and myelin sheaths formation. To further determine the targeting stage of gastrodin, we first examined the number of oligodendrocyte linage cells by Tg(Olig2:eGFP), which labels OL lineage cells ranging from OPCs to myelinating OLs (Supplementary Fig. S<xref rid="MOESM6" ref-type="media">1b</xref>). There was no difference in the number of dorsal Olig2<sup>+</sup> cells between gastrodin-treated larvae and control at 3 and 5 dpf (Supplementary Fig. S<xref rid="MOESM6" ref-type="media">1c, d</xref>), suggesting gastrodin has no effect on the number of OL lineage cells.</p><p id="Par29">Furthermore, by crossing Tg(MBP:Gal4) with Tg(5xUAS:GFP), in which OLs were labeled by GFP, we also found that gastrodin did not affect the number of MBP<sup>+</sup> mature OLs (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a&#x02013;c</xref>). To further investigate the myelinating capability of individual oligodendrocytes, we injected both sox10:mRFP and sox10:eGFP plasmids into fertilized eggs at the one-cell stage to mosaically label individual OLs (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2d</xref>). The red fluorescence labeled the membrane and the green fluorescence labeled the cell body (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2e</xref>). Time-lapse imaging showed the dynamic development of a single representative OL from 3 dpf to 7 dpf, and revealed that myelin fragments were more abundant formed by the gastrodin-treated OL (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2e</xref>). Furthermore, the average number of myelin sheaths per OL was increased dramatically in gastrodin-treated larvae at 7 dpf (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2f</xref>). Thus, these collective evidences indicate that gastrodin promotes myelination primarily by enhancing the myelinogenic capacity.<fig id="Fig2"><label>Fig. 2</label><caption><title>Gastrodin promotes myelin sheath formation.</title><p><bold>a</bold> Schematic of Tg(MBP:Gal4) &#x00026; Tg(5&#x000d7;UAS:GFP) imaging pipeline. <bold>b</bold> Representative images showing lateral views of the spinal cords at 5 dpf. <bold>c</bold> Quantification of GFP<sup>+</sup> cells number in the ventral or dorsal spinal cord (<italic>n</italic>&#x02009;=&#x02009;12&#x02013;14 zebrafish). <bold>d</bold> Schematic of DNA microinjection and imaging pipeline. <bold>e</bold> Time-lapse imaging of myelin sheath development of a single OL from 3 dpf to 7 dpf. <bold>f</bold> Representative images showing myelin sheaths formed by a single OL at 7 dpf and quantification of myelin sheath number per OL (<italic>n</italic>&#x02009;=&#x02009;42&#x02013;60 OLs). Data are represented as mean&#x02009;&#x000b1;&#x02009;SEM, unpaired Student&#x02019;s <italic>t</italic> test in <bold>c</bold> and <bold>f</bold>.</p></caption><graphic xlink:href="41401_2025_1492_Fig2_HTML" id="d33e607"/></fig></p></sec><sec id="Sec25"><title>Gastrodin promotes OL maturation</title><p id="Par30">Next, we assessed the role of gastrodin in primary cultured OPCs (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a</xref>). After treatment with different concentrations of gastrodin, we found that 10&#x02009;&#x003bc;M gastrodin led to a greater increase in MBP expression compared to other concentrations (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3b</xref>, c). On the second day of in vitro differentiation, gastrodin promoted the differentiation of a larger proportion of PDGFR&#x003b1;<sup>+</sup> OPCs into CC1<sup>+</sup> OLs (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3d</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><title>Gastrodin promotes OL maturation in vitro.</title><p><bold>a</bold> Schematic depicting OPCs culture and gastrodin treatment. <bold>b</bold> Western blot for MBP after 1, 10, 50&#x02009;&#x003bc;M gastrodin treatment. <bold>c</bold> Quantification of relative MBP protein levels (<italic>n</italic>&#x02009;=&#x02009;3 experiments). <bold>d</bold> Representative images of PDGFR&#x003b1; (red), CC1 (green), and Olig2 (blue) immunofluorescence and quantification of proportion of CC1<sup>+</sup> cells or PDGFR&#x003b1;<sup>+</sup> cells in Olig2<sup>+</sup> cells (<italic>n</italic>&#x02009;=&#x02009;3 experiments). <bold>e</bold> Representative images of OLs membrane area of MBP<sup>+</sup> cells, depicting different degrees of OL maturation. Low differentiation, OLs without membrane; Medium differentiation, OLs with a few membranes; High differentiation, OLs with large area of membrane. <bold>f</bold> Representative images of MBP (red) and Sox10 (green) immunofluorescence. White boxes zoom in are shown on the right. <bold>g</bold> Quantification of MBP<sup>+</sup> cells&#x02019; proportion in different maturation degrees (<italic>n</italic>&#x02009;=&#x02009;3 experiments). <bold>h</bold> Quantification of MBP<sup>+</sup> area (<italic>n</italic>&#x02009;=&#x02009;3 experiments). <bold>i</bold> Quantification of proportion of MBP<sup>+</sup> cells in Sox10<sup>+</sup> cells (<italic>n</italic>&#x02009;=&#x02009;3 experiments). <bold>j</bold> Schematic depicting MO3.13 oligodendroglial cell line culture and gastrodin treatment. <bold>k</bold> qPCR analysis of <italic>Mbp</italic> and <italic>Plp1</italic> after 10 and 50&#x02009;&#x003bc;M gastrodin treatment (<italic>n</italic>&#x02009;=&#x02009;3 experiments). Data are represented as mean&#x02009;&#x000b1;&#x02009;SEM, One-way ANOVA and Dunnett-<italic>t</italic> in <bold>c</bold>, unpaired Student&#x02019;s <italic>t</italic> test in <bold>d</bold>, <bold>g</bold>&#x02013;<bold>i</bold>, and <bold>k</bold>.</p></caption><graphic xlink:href="41401_2025_1492_Fig3_HTML" id="d33e732"/></fig></p><p id="Par31">OPC differentiation into mature OLs is accompanied with expansion of cell branching complexity and membrane morphology [<xref ref-type="bibr" rid="CR43">43</xref>]. As shown in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3e</xref>, MBP staining displayed different degrees of OL maturation. We found that gastrodin significantly enhanced OLs membrane expansion and sheet formation on the third day of in vitro differentiation (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3f</xref>). Triiodothyronine (T3), an effective inducer of OPC differentiation and maturation [<xref ref-type="bibr" rid="CR44">44</xref>], was used as a positive control. Morphometric and quantitative analysis showed that the branching complexity of OLs was generally higher, and MBP<sup>+</sup> membrane area increased after gastrodin treatment (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3g, h</xref>). However, there was no difference in the proportion of MBP<sup>+</sup> cells in OLs after gastrodin treatment (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3i</xref>), indicating that gastrodin primarily impacts the differentiation status of OL, rather than the number of mature OLs. In addition, gastrodin treatment did not affect OPC proliferation or apoptosis as revealed by 5-Bromo-2&#x02019;-deoxyuridine (BrdU) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining (Supplementary Fig. S<xref rid="MOESM6" ref-type="media">2a&#x02013;e</xref>).</p><p id="Par32">To test whether gastrodin promotes human oligodendrocyte differentiation, we treated MO3.13 human OLs using 10&#x02009;&#x003bc;M and 50&#x02009;&#x003bc;M gastrodin (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3j</xref>). qPCR analysis showed that 50&#x02009;&#x003bc;M gastrodin significantly increased the levels of <italic>Mbp</italic> and <italic>Plp1</italic> (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3k</xref>). Together, these observations confirm that gastrodin promotes OL maturation in vitro.</p></sec><sec id="Sec26"><title>Gastrodin activates PI3K/AKT/mTOR signaling pathway in OLs</title><p id="Par33">Previous studies have demonstrated that the phosphatidylinositol 3-kinase (PI3K), adenosine 5&#x02019;-monophosphate (AMP)-activated protein kinase (AMPK), and Wnt signaling pathways are involved in regulation of myelination [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. To elucidate the specific signaling pathway underlying the promotion of OL maturation by gastrodin, we examined the expression of key proteins along the above signaling pathways. Western blot showed that gastrodin did not affect the levels of &#x003b2;-catenin and AMPK phosphorylation in the OLs (Supplementary Fig. S<xref rid="MOESM6" ref-type="media">3a&#x02013;c</xref>). While phosphorylation levels of PI3K, protein kinase B (PKB, aka AKT), and mammalian target of rapamycin (mTOR) were significantly increased in the gastrodin-treated OLs (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4a</xref>, b), indicating that gastrodin activated the PI3K signaling pathway.<fig id="Fig4"><label>Fig. 4</label><caption><title>Gastrodin activates PI3K/AKT/mTOR signaling pathway in OLs.</title><p><bold>a</bold> Western blot for p-PI3K, PI3K, p-AKT, AKT, p-mTOR, mTOR and MBP. <bold>b</bold> Quantification of the ratio of p-PI3K/PI3K, p-AKT/AKT, and p-mTOR/mTOR (<italic>n</italic>&#x02009;=&#x02009;6 experiments). <bold>c</bold> The predicted binding model of gastrodin-PI3K complex by molecular docking. <bold>d</bold> Molecular dynamic simulation showing the plot of RMSD (in &#x000e5;ngstrom) of the complex during 100&#x02009;ns MD simulation. <bold>e</bold> RMSF values of PI3K during molecular dynamic simulations. Protein residues that interact with the ligand are marked with green-colored vertical bars. <bold>f</bold> A schematic of detailed ligand atom interactions with the protein residues. Interactions that occur for more than 30.0% of the simulation time in the selected trajectory (0.00 to 100.00&#x02009;ns) are shown. <bold>g</bold> Western blot and quantification of relative PI3K protein levels (<italic>n</italic>&#x02009;=&#x02009;3 experiments). Cell lysis was incubated with gastrodin and then subjected to proteinase K (PK). <bold>h</bold> Cellular Thermal Shift Assay, effect of gastrodin on the thermal stability of PI3K and quantification of relative PI3K protein levels (<italic>n</italic>&#x02009;=&#x02009;3 experiments). <bold>i</bold> Schematic depicting OPCs culture with gastrodin and LY294002 (LY) treatment. <bold>j</bold> Western blot for p-PI3K and PI3K and quantification of the ratio of p-PI3K/PI3K (<italic>n</italic>&#x02009;=&#x02009;3 experiments). <bold>k</bold> Western blot for p-mTOR, mTOR, p-AKT, AKT, and MBP. <bold>l</bold> Quantification of relative MBP protein levels and the ratio of p-mTOR/mTOR and p-AKT/AKT (<italic>n</italic>&#x02009;=&#x02009;5 experiments). <bold>m</bold> Left:&#x000a0;Representative images of MBP (red) and Sox10 (green) immunofluorescence. Right: Quantification of MBP<sup>+</sup> area (<italic>n</italic>&#x02009;=&#x02009;3 experiments). Data are represented as mean&#x02009;&#x000b1;&#x02009;SEM, unpaired Student&#x02019;s <italic>t</italic> test in <bold>b</bold>, <bold>g</bold>, <bold>j</bold>, <bold>l</bold>, and <bold>m</bold>.</p></caption><graphic xlink:href="41401_2025_1492_Fig4_HTML" id="d33e879"/></fig></p><p id="Par34">To gain further structural insight into the mechanism by which gastrodin regulates the PI3K signaling pathway, molecular docking was performed to predict whether there is a direct interaction between gastrodin and PI3K. The analysis revealed that gastrodin binds to the PI3K with an affinity of &#x02212;7.1&#x02009;kcal/mol, primarily through hydrogen bonds at LEU393, TYR496, GLN645 (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4c</xref>). Dynamic simulation confirmed the stability of this interaction, with the complex stabilizing in 100&#x02009;ns, as indicated by the root mean square deviation (RMSD) results (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4d</xref>). The RMS fluctuations (RMSFs) during the simulation were plotted to further assess the local structural flexibility. The minimal fluctuations in majority of amino acids suggested strong binding (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4e</xref>). In addition, multiple sets of forces such as hydrogen bonds and water bridges were formed between gastrodin and PI3K (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4f</xref>). Drug affinity responsive target stability (DARTS) revealed that the proteolysis of PI3K protein by proteinase K was attenuated in the presences of gastrodin (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4g</xref>). Correspondingly, cellular thermal shift assay (CETSA) demonstrated that gastrodin also increased the thermal stability of PI3K protein (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4h</xref>). These results support the potential of PI3K as a target of gastrodin in OLs and provide insight into its mechanisms of action.</p><p id="Par35">We then co-treated OPCs with gastrodin and the PI3K inhibitor LY294002 (5&#x02009;&#x000b5;M). LY294002 could effectively reduce the phosphorylation level of PI3K (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4i, j</xref>). Meanwhile, LY294002 also inhibited the phosphorylation levels of AKT and mTOR (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4k, l</xref>). In particular, the MBP protein level was significantly reduced in gastrodin-treated OLs after LY294002 treatment, as confirmed by immunofluorescence staining results showing that the area of MBP fluorescence was also reduced by LY294002 (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4k&#x02013;m</xref>). Taken together, gastrodin promotes OL maturation by activating the PI3K/AKT/mTOR signaling pathway, probably through a direct interaction with PI3K.</p></sec><sec id="Sec27"><title>Gastrodin promotes remyelination after LPC-induced demyelination</title><p id="Par36">To examine whether gastrodin promotes remyelination in vivo, we used a lysophosphatidylcholine (LPC)-induced demyelination model [<xref ref-type="bibr" rid="CR46">46</xref>]. Several animal studies based on gastrodin have shown that 100&#x02009;mg/kg is a commonly used and effective dosage. Wang et al. found that gastrodin (100&#x02009;mg/kg) suppresses neuroinflammation and microglial activation in LPS-treated mice [<xref ref-type="bibr" rid="CR29">29</xref>]. Song et al. also reported that gastrodin (100&#x02009;mg/kg) might alleviate the LPS-induced neuroinflammation and depressive-anxiety-like behaviors in mice [<xref ref-type="bibr" rid="CR47">47</xref>]. Therefore, we test the effect of 100&#x02009;mg/kg gastrodine in the LPC model. LPC injury was induced in the corpus callosum of adult mice that were treated with gastrodin or vehicle daily (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5a</xref>). Apparent demyelinating lesions were shown at 7 days post-lesion (dpl), but there was no significant difference in the demyelinating area between gastrodin-treated mice and vehicle-treated mice (Supplementary Fig. S<xref rid="MOESM6" ref-type="media">4a, b</xref>).<fig id="Fig5"><label>Fig. 5</label><caption><title>Gastrodin promotes remyelination after LPC-induced demyelination.</title><p><bold>a</bold> Schematic depicting LPC-induced demyelination model. <bold>b</bold> LFB staining showing the serial demyelinating region in the corpus callosum. Lesions are shown in the black dotted line. <bold>c</bold> Quantification of the demyelination volume at 14 dpl (<italic>n</italic>&#x02009;=&#x02009;3 mice). <bold>d</bold> Representative images of MBP (red) in the core lesion. Lesions are shown in the white dotted line. <bold>e</bold> Quantification of MBP<sup>-</sup> demyelinated area (<italic>n</italic>&#x02009;=&#x02009;3 mice). <bold>f</bold> Representative images of Olig2 (blue) and PDGFR&#x003b1; (green) in the core lesion at 14 dpl. Lesions are shown in the white dotted line. <bold>g</bold> Quantification of Olig2<sup>+</sup> cells/mm<sup>2</sup> and PDGFR&#x003b1;<sup>+</sup> cells/mm<sup>2</sup> in the core lesion (<italic>n</italic>&#x02009;=&#x02009;3 mice). <bold>h</bold> Representative images of BrdU (red) and CC1 (green) immunofluorescence in the core lesion at 14 dpl. Lesions are shown in the white dotted line, and white boxes zoom in are shown on the right. <bold>i</bold> Quantification of CC1<sup>+</sup> cells/mm<sup>2</sup> and BrdU<sup>+</sup>CC1<sup>+</sup> cells/mm<sup>2</sup> in the core lesion (<italic>n</italic>&#x02009;=&#x02009;3 mice). <bold>j</bold> TEM images of the LPC-lesioned corpus callosum at 21 dpl. White boxes zoom in are shown below. M Myelinated axon, U Unmyelinated axon. <bold>k</bold>, <bold>l</bold> Quantification of g-ratio and proportion of myelinated axons in the LPC-lesioned corpus callosum at 21 dpl (<italic>n</italic>&#x02009;=&#x02009;3 mice). Data are presented as mean&#x02009;&#x000b1;&#x02009;SEM, unpaired Student&#x02019;s <italic>t</italic> test in <bold>c</bold>, <bold>e</bold>, <bold>g</bold>, <bold>i</bold>, <bold>k</bold>, and <bold>l</bold>.</p></caption><graphic xlink:href="41401_2025_1492_Fig5_HTML" id="d33e1036"/></fig></p><p id="Par37">It has been reported that remyelination starts at around 14 dpl [<xref ref-type="bibr" rid="CR46">46</xref>]. Compared to the vehicle-treated mice, markedly reduced demyelination volume was observed in the gastrodin-treated mice at 14 dpl (Supplementary Fig.&#x000a0;<xref rid="MOESM6" ref-type="media">5b, c</xref>). Immunofluorescence staining of MBP revealed the demyelinated area at the core lesion (LPC injection site) was smaller in gastrodin-treated mice at 14 dpl (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5d</xref>). Besides, the gastrodin-treated lesions exhibited a greater number of Olig2<sup>+</sup> cells and a reduction in PDGFR&#x003b1;<sup>+</sup> cells at 14 dpl (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5f, g</xref>). We then administered BrdU intraperitoneally to mice from 8 dpl to 14 dpl. The results demonstrated a notable elevation in CC1<sup>+</sup> cells within the lesions following gastrodin treatment. Additionally, the number of BrdU<sup>+</sup>CC1<sup>+</sup> cells (newly formed mature OLs) was higher in the gastrodin-treated mice, although this difference was not statistically significant (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5h</xref>, i). Moreover, transmission electron microscopy indicated significantly thicker myelin sheaths and higher proportion of myelinated axons in the gastrodin-treated lesions at 21 dpl (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5j&#x02013;l</xref>). These observations suggest that gastrodin treatment effectively facilitates the remyelination process in vivo.</p></sec><sec id="Sec28"><title>Gastrodin enhances remyelination in EAE mice</title><p id="Par38">Experimental autoimmune encephalomyelitis (EAE) is a commonly used experimental model for MS [<xref ref-type="bibr" rid="CR48">48</xref>]. To explore the impact of gastrodin in the EAE model, we treated EAE mice with 100&#x02009;mg/kg gastrodin daily beginning on either one day post-immunization (dpi) or disease peak with the highest clinical score (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6a</xref>). We recorded the clinical scores of the mice daily and found that initial treatment of gastrodin delayed the onset of symptoms mainly ranging from tail weakness to hindlimb paralysis and effectively suppressed the severity of EAE (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6b</xref>). When gastrodin was administered from the disease peak, the severity of EAE was also lower in gastrodin-treated mice than in controls (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6c</xref>). Notably, smaller demyelinating lesions were observed in the lumbar spinal cord of gastrodin-treated mice (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6d</xref>), consistent with a higher proportion of MBP<sup>+</sup> area after gastrodin treatment (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6e</xref>). Moreover, the extent of remyelination was higher in gastrodin-treated mice correlating with an increased number of CC1<sup>+</sup>Sox10<sup>+</sup> mature OLs at 30 dpi (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6f</xref>). Thus, gastrodin treatment alleviates immune-induced demyelination damage and enhances remyelination.<fig id="Fig6"><label>Fig. 6</label><caption><title>Gastrodin treatment effectively enhances remyelination in EAE mice.</title><p><bold>a</bold> Schematic depicting EAE model and gastrodin treatment (gastrodin setting, 100&#x02009;mg/kg ip). IT: initial treatment, PT: Peak treatment. <bold>b</bold>, <bold>c</bold> Clinical score in EAE mice treated at 1 dpi (left) or treated at disease peak (right) with gastrodin or vehicle (<italic>n</italic>&#x02009;=&#x02009;6&#x02013;10 mice). <bold>d</bold> LFB staining of spinal cord sections at 30 dpi (left) and quantification of the demyelinated white matter&#x02019;s percentage (right, <italic>n</italic>&#x02009;=&#x02009;3 mice). Black boxes zoom in are shown below. <bold>e</bold> Representative images of MBP (green) immunofluorescence in spinal cord sections at 30 dpi (left) and quantification of MBP<sup>+</sup> area&#x02019;s percentage (right, <italic>n</italic>&#x02009;=&#x02009;3 mice). <bold>f</bold> Representative images of CC1 (red) and Sox10 (green) immunofluorescence around lesions at 30 dpi (left), and quantification of CC1<sup>+</sup>Sox10<sup>+</sup> cells/mm<sup>2</sup> (right, <italic>n</italic>&#x02009;=&#x02009;3 mice). White boxes zoom in are shown below. Data are represented as mean&#x02009;&#x000b1;&#x02009;SEM, Mann&#x02013;Whitney U in <bold>b</bold> and <bold>c</bold>, one-way ANOVA with Tukey in <bold>d</bold>&#x02013;<bold>f</bold>.</p></caption><graphic xlink:href="41401_2025_1492_Fig6_HTML" id="d33e1159"/></fig></p></sec></sec><sec id="Sec29" sec-type="discussion"><title>Discussion</title><p id="Par39">Demyelination is one of the typical pathological manifestations of numerous CNS disorders such as MS. Although endogenous remyelination often occurs following demyelination, the process often fails primarily due to two barriers: (1) impaired differentiation of OPCs and (2) reduced myelin generation capacity [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. As the pivotal cells for remyelination, OL lineage cells have become a major target for promoting myelin repair [<xref ref-type="bibr" rid="CR50">50</xref>]. Several medications aimed at enhancing OPC differentiation have been tested in patients with MS, including clemastine (a first-generation antihistamine) [<xref ref-type="bibr" rid="CR10">10</xref>], opicinumab (a human monoclonal antibody against LINGO-1) [<xref ref-type="bibr" rid="CR51">51</xref>], and bexarotene (a clinically approved RXR agonist) [<xref ref-type="bibr" rid="CR52">52</xref>]. Although some of them have shown efficacy, they are not as effective as expected. None of them has been approved clinically [<xref ref-type="bibr" rid="CR53">53</xref>]. One reason may be that the complex microenvironment at the demyelinating lesion of patients is not conducive to OPC differentiation. Several evidences also indicate large number of residual OLs in MS lesions failing to properly remyelinate axons [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. A recent study demonstrated that therapeutic reversal of epigenetic silencing to reactivate myelin production by mature or newly formed OLs may be necessary to enable myelin regeneration [<xref ref-type="bibr" rid="CR6">6</xref>]. Therefore, it is essential to develop screening strategies based on enhancing myelinogenic capacity.</p><p id="Par40">Zebrafish, as a vertebrate, well retains cellular functions comparable to those of mammals [<xref ref-type="bibr" rid="CR56">56</xref>]. Using zebrafish as a screening model in this study was took of their transparency during juvenile stages and their skin permeability which enables direct absorption of small molecule compounds [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. Furthermore, several different transgenic lines were used to allow dynamic observation of OPC migration, maturation and myelination. In particular, the microinjection of a fluorescent plasmid targeting OLs allowed the observation of myelin development in single OL. Unlike previous cellular level screening compounds, we used the Tg(MBP:eGFP-CAAX) larval as well as the Sox10:mRFP plasmid to ultimately assess the degree of myelination in vivo rather than the degree of OPC differentiation. Using this model, we successfully screened gastrodin as a pro-myelinating candidate from five TCM monomers.</p><p id="Par41">Gastrodin, a compound purified from the notable herbal plant <italic>Gastrodia elata</italic> Blume, is able to pass through the blood-brain barrier and is rapidly distributed in the brain after it enters the systematic circulation [<xref ref-type="bibr" rid="CR59">59</xref>]. Nowadays, gastrodin has been clinically used as an adjuvant therapy for several neurological disorders such as refractory epilepsy, Parkinson&#x02019;s, and post-stroke depression [<xref ref-type="bibr" rid="CR60">60</xref>]. The various effects of gastrodin including mitigating oxidative stress, anti-neuroinflammation, neurotrophic effects and inhibition of neuronal apoptosis would underlie its neuroprotective functions [<xref ref-type="bibr" rid="CR61">61</xref>&#x02013;<xref ref-type="bibr" rid="CR63">63</xref>]. Previous study has reported that gastrodin can increase CNS remyelination by increasing OPC differentiation [<xref ref-type="bibr" rid="CR64">64</xref>]. It has also been reported that gastrodin significantly enhanced the proliferation, migration and myelination of Schwann cells [<xref ref-type="bibr" rid="CR65">65</xref>]. In comparison, based on dynamic observations in zebrafish, our findings indicated that gastrodin predominantly stimulated the production of myelin fragments from individual OL without affecting the number of mature OLs. Similarly, although in vitro experiments demonstrated that gastrodin enhanced the proportion of CC1<sup>+</sup> cells during differentiation, there was no longer a discernible difference in the number of MBP<sup>+</sup> cells at the subsequent stages of differentiation. Instead, gastrodin mainly affected the branching complexity of mature OLs.</p><p id="Par42">Herein, we demonstrated that gastrodin enhanced myelination via activation of the PI3K/AKT/mTOR signaling pathway in OLs. Activation of PI3K phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2) to form phosphatidylinositol 3,4,5-trisphosphate (PIP3), which then phosphorylates the serine-threonine kinase AKT, activating mTORC1 [<xref ref-type="bibr" rid="CR66">66</xref>]. mTORC1 regulates ribosomal protein S6 kinase beta-1 and sterol regulatory element-binding proteins, which are essential transcription factors for the expression of myelin proteins and enzymes involved in lipid synthesis [<xref ref-type="bibr" rid="CR67">67</xref>]. Previous studies have reported that gastrodin exerts neuroprotective effects through activating the PI3K/AKT signaling pathway in microglia, astrocytes, Schwann cells, and retinal precursor cells [<xref ref-type="bibr" rid="CR68">68</xref>&#x02013;<xref ref-type="bibr" rid="CR71">71</xref>]. In this study, we found that gastrodin significantly increased the phosphorylation level of PI3K and its downstream proteins in OLs, consequently enhancing the expression of myelin proteins. This effect could be effectively impeded by the PI3K inhibitor LY294002. It is worth noting that through computational predictions and biological evidence, gastrodin had a strong binding effect with PI3K, implying that the activation of PI3K/AKT signaling pathway by gastrodin may be related to its direct binding to PI3K. Further investigation is required to ascertain whether this binding is necessary to increase the level of PI3K phosphorylation.</p><p id="Par43">In recent years, several emerging therapeutic strategies have been developed to promote myelination. For instance, the modulation of neuron-oligodendrocyte interactions induces myelination, known as adaptive myelination. Erin M. Gibson et al. have found that optogenetic activation of the premotor cortex can promote oligodendrogenesis and improve myelination in the corpus callosum [<xref ref-type="bibr" rid="CR72">72</xref>]. Based on this finding, repeated optogenetic activation of demyelinated axons in the motor cortex promotes remyelination and functional restoration of conduction [<xref ref-type="bibr" rid="CR73">73</xref>]. It has also been reported that activating glutamatergic neurons in the medial prefrontal cortex using optogenetics and chemical genetics promotes the differentiation of OPCs in the corpus callosum, which improves myelin repair and working memory [<xref ref-type="bibr" rid="CR74">74</xref>]. However, these invasive approaches have not yet reached the stage of clinical implementation, unlike pharmacological pro-myelination strategies. In addition, some therapies that target improvement of the pathological microenvironment, particularly neuroinflammation can also promote remyelination. For example, myelin debris impedes OPC differentiation, and niacin (vitamin B3) promotes myelin debris clearance in lesions by peripheral-derived macrophages and microglia [<xref ref-type="bibr" rid="CR75">75</xref>]. Moreover, microglia and macrophages synthesize desmosterol which can activate liver X receptor to resolve inflammation and create a permissive environment for OPC differentiation, suggesting that pharmacological stimulation of sterol synthesis has the potential to boost the repair of demyelinated lesions [<xref ref-type="bibr" rid="CR76">76</xref>]. The anti-inflammatory effects of gastrodin have been highlighted in several prior studies [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR77">77</xref>&#x02013;<xref ref-type="bibr" rid="CR79">79</xref>]. Our findings indicated that gastrodin effectively reduced inflammation while ameliorating myelin defects in the LPC and EAE models, with a milder activation of microglia and astrocytes at the lesions after gastrodin treatment (Supplementary Fig. S<xref rid="MOESM6" ref-type="media">5a&#x02013;e</xref>). The anti-inflammatory mechanism of gastrodin in demyelinating diseases remains unclear, yet this aspect warrants further investigation. A dual effect of gastrodin, promoting myelinogenesis and anti-inflammation, strongly indicates the therapeutical potential for the treatment of MS, especially at the chronic-progressive stage.</p><p id="Par44">In summary, our study provides a great promise in zebrafish screening model for pro-myelination drugs and suggests gastrodin as a potential agent for the treatment of demyelinating diseases (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>).<fig id="Fig7"><label>Fig. 7</label><caption><p>Schematic illustration of drug screening and pro-myelinogenesis effect of gastrodin via PI3K/AKT/mTOR signaling pathway.</p></caption><graphic xlink:href="41401_2025_1492_Fig7_HTML" id="d33e1289"/></fig></p></sec><sec id="Sec30" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41401_2025_1492_MOESM1_ESM.jpg"><caption><p>Supplementary Figure S1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41401_2025_1492_MOESM2_ESM.jpg"><caption><p>Supplementary Figure S2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41401_2025_1492_MOESM3_ESM.jpg"><caption><p>Supplementary Figure S3</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41401_2025_1492_MOESM4_ESM.jpg"><caption><p>Supplementary Figure S4</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41401_2025_1492_MOESM5_ESM.jpg"><caption><p>Supplementary Figure S5</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="41401_2025_1492_MOESM6_ESM.docx"><caption><p>Supplementary Figures legend</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Xiao-yu Shi, Yi-xi He, Man-yue Ge</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41401-025-01492-z.</p></sec><ack><title>Acknowledgements</title><p>This work was supported by the National Natural Science Foundation of China (32100798 and 82401564), the Ministry of Science and Technology of China STI2030-Major Projects (2022ZD0204700), Foundation of Naval Medical University (2023QN010), and Yizhang Talent Programme of Basic Medical College, Naval Medical University (JCYZRC-D-009).</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>XYS, YXH, and ZHL designed research; XYS, YXH, MYG, and ZHL performed research and analyzed data; PL, PZ, and ZHL provided the main technical support; XYS and YXH wrote the draft; PL, PZ, and ZHL revised the manuscript.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par45">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Osso</surname><given-names>LA</given-names></name><name><surname>Hughes</surname><given-names>EG</given-names></name></person-group><article-title>Dynamics of mature myelin</article-title><source>Nat Neurosci</source><year>2024</year><volume>27</volume><fpage>1449</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1038/s41593-024-01642-2</pub-id><pub-id pub-id-type="pmid">38773349</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Osso LA, Hughes EG. Dynamics of mature myelin. Nat Neurosci. 2024;27:1449&#x02013;61.<pub-id pub-id-type="pmid">38773349</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Nave</surname><given-names>KA</given-names></name><name><surname>Werner</surname><given-names>HB</given-names></name></person-group><article-title>Myelination of the nervous system: mechanisms and functions</article-title><source>Annu Rev Cell Dev Biol</source><year>2014</year><volume>30</volume><fpage>503</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100913-013101</pub-id><pub-id pub-id-type="pmid">25288117</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Nave KA, Werner HB. Myelination of the nervous system: mechanisms and functions. Annu Rev Cell Dev Biol. 2014;30:503&#x02013;33.<pub-id pub-id-type="pmid">25288117</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">Kornberg MD, Calabresi PA. Multiple sclerosis and other acquired demyelinating diseases of the central nervous system. Cold Spring Harb Perspect Biol. 2024;28:a041374.</mixed-citation></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Franklin</surname><given-names>RJ</given-names></name><name><surname>Goldman</surname><given-names>SA</given-names></name></person-group><article-title>Glia disease and repair-remyelination</article-title><source>Cold Spring Harb Perspect Biol</source><year>2015</year><volume>7</volume><fpage>a020594</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a020594</pub-id><pub-id pub-id-type="pmid">25986556</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Franklin RJ, Goldman SA. Glia disease and repair-remyelination. Cold Spring Harb Perspect Biol. 2015;7:a020594.<pub-id pub-id-type="pmid">25986556</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Franklin</surname><given-names>RJM</given-names></name><name><surname>Ffrench-Constant</surname><given-names>C</given-names></name></person-group><article-title>Regenerating CNS myelin - from mechanisms to experimental medicines</article-title><source>Nat Rev Neurosci</source><year>2017</year><volume>18</volume><fpage>753</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1038/nrn.2017.136</pub-id><pub-id pub-id-type="pmid">29142295</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Franklin RJM, Ffrench-Constant C. Regenerating CNS myelin - from mechanisms to experimental medicines. Nat Rev Neurosci. 2017;18:753&#x02013;69.<pub-id pub-id-type="pmid">29142295</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Xin</surname><given-names>DE</given-names></name><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Small-molecule-induced epigenetic rejuvenation promotes SREBP condensation and overcomes barriers to CNS myelin regeneration</article-title><source>Cell</source><year>2024</year><volume>187</volume><fpage>2465</fpage><lpage>84.e22</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2024.04.005</pub-id><pub-id pub-id-type="pmid">38701782</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Liu X, Xin DE, Zhong X, Zhao C, Li Z, Zhang L, et al. Small-molecule-induced epigenetic rejuvenation promotes SREBP condensation and overcomes barriers to CNS myelin regeneration. Cell. 2024;187:2465&#x02013;84.e22.<pub-id pub-id-type="pmid">38701782</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhlmann</surname><given-names>T</given-names></name><name><surname>Miron</surname><given-names>V</given-names></name><name><surname>Cui</surname><given-names>Q</given-names></name><name><surname>Wegner</surname><given-names>C</given-names></name><name><surname>Antel</surname><given-names>J</given-names></name><name><surname>Bruck</surname><given-names>W</given-names></name></person-group><article-title>Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis</article-title><source>Brain</source><year>2008</year><volume>131</volume><fpage>1749</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1093/brain/awn096</pub-id><pub-id pub-id-type="pmid">18515322</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Kuhlmann T, Miron V, Cui Q, Wegner C, Antel J, Bruck W. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain. 2008;131:1749&#x02013;58.<pub-id pub-id-type="pmid">18515322</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Yeung</surname><given-names>MSY</given-names></name><name><surname>Djelloul</surname><given-names>M</given-names></name><name><surname>Steiner</surname><given-names>E</given-names></name><name><surname>Bernard</surname><given-names>S</given-names></name><name><surname>Salehpour</surname><given-names>M</given-names></name><name><surname>Possnert</surname><given-names>G</given-names></name><etal/></person-group><article-title>Dynamics of oligodendrocyte generation in multiple sclerosis</article-title><source>Nature</source><year>2019</year><volume>566</volume><fpage>538</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0842-3</pub-id><pub-id pub-id-type="pmid">30675058</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Yeung MSY, Djelloul M, Steiner E, Bernard S, Salehpour M, Possnert G, et al. Dynamics of oligodendrocyte generation in multiple sclerosis. Nature. 2019;566:538&#x02013;42.<pub-id pub-id-type="pmid">30675058</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>KLH</given-names></name><name><surname>Early</surname><given-names>JJ</given-names></name><name><surname>Lyons</surname><given-names>DA</given-names></name></person-group><article-title>Drug discovery for remyelination and treatment of MS</article-title><source>Glia</source><year>2017</year><volume>65</volume><fpage>1565</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1002/glia.23166</pub-id><pub-id pub-id-type="pmid">28618073</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Cole KLH, Early JJ, Lyons DA. Drug discovery for remyelination and treatment of MS. Glia. 2017;65:1565&#x02013;89.<pub-id pub-id-type="pmid">28618073</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>AJ</given-names></name><name><surname>Gelfand</surname><given-names>JM</given-names></name><name><surname>Cree</surname><given-names>BA</given-names></name><name><surname>Bevan</surname><given-names>C</given-names></name><name><surname>Boscardin</surname><given-names>WJ</given-names></name><name><surname>Mei</surname><given-names>F</given-names></name><etal/></person-group><article-title>Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial</article-title><source>Lancet</source><year>2017</year><volume>390</volume><fpage>2481</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(17)32346-2</pub-id><pub-id pub-id-type="pmid">29029896</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, et al. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet. 2017;390:2481&#x02013;9.<pub-id pub-id-type="pmid">29029896</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Masson</surname><given-names>MA</given-names></name><name><surname>Nait-Oumesmar</surname><given-names>B</given-names></name></person-group><article-title>Emerging concepts in oligodendrocyte and myelin formation, inputs from the zebrafish model</article-title><source>Glia</source><year>2023</year><volume>71</volume><fpage>1147</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1002/glia.24336</pub-id><pub-id pub-id-type="pmid">36645033</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Masson MA, Nait-Oumesmar B. Emerging concepts in oligodendrocyte and myelin formation, inputs from the zebrafish model. Glia. 2023;71:1147&#x02013;63.<pub-id pub-id-type="pmid">36645033</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Czopka</surname><given-names>T</given-names></name></person-group><article-title>Insights into mechanisms of central nervous system myelination using zebrafish</article-title><source>Glia</source><year>2016</year><volume>64</volume><fpage>333</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1002/glia.22897</pub-id><pub-id pub-id-type="pmid">26250418</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Czopka T. Insights into mechanisms of central nervous system myelination using zebrafish. Glia. 2016;64:333&#x02013;49.<pub-id pub-id-type="pmid">26250418</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>MacRae</surname><given-names>CA</given-names></name><name><surname>Peterson</surname><given-names>RT</given-names></name></person-group><article-title>Zebrafish as tools for drug discovery</article-title><source>Nat Rev Drug Discov</source><year>2015</year><volume>14</volume><fpage>721</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1038/nrd4627</pub-id><pub-id pub-id-type="pmid">26361349</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">MacRae CA, Peterson RT. Zebrafish as tools for drug discovery. Nat Rev Drug Discov. 2015;14:721&#x02013;31.<pub-id pub-id-type="pmid">26361349</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Oprisoreanu</surname><given-names>AM</given-names></name><name><surname>Ryan</surname><given-names>F</given-names></name><name><surname>Richmond</surname><given-names>C</given-names></name><name><surname>Dzekhtsiarova</surname><given-names>Y</given-names></name><name><surname>Carragher</surname><given-names>NO</given-names></name><name><surname>Becker</surname><given-names>T</given-names></name><etal/></person-group><article-title>Drug screening in zebrafish larvae reveals inflammation-related modulators of secondary damage after spinal cord injury in mice</article-title><source>Theranostics</source><year>2023</year><volume>13</volume><fpage>2531</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.7150/thno.81332</pub-id><pub-id pub-id-type="pmid">37215570</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Oprisoreanu AM, Ryan F, Richmond C, Dzekhtsiarova Y, Carragher NO, Becker T, et al. Drug screening in zebrafish larvae reveals inflammation-related modulators of secondary damage after spinal cord injury in mice. Theranostics. 2023;13:2531&#x02013;51.<pub-id pub-id-type="pmid">37215570</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>RG</given-names></name><name><surname>Czopka</surname><given-names>T</given-names></name><name><surname>Ffrench-Constant</surname><given-names>C</given-names></name><name><surname>Lyons</surname><given-names>DA</given-names></name></person-group><article-title>Individual axons regulate the myelinating potential of single oligodendrocytes in vivo</article-title><source>Development</source><year>2011</year><volume>138</volume><fpage>4443</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1242/dev.071001</pub-id><pub-id pub-id-type="pmid">21880787</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Almeida RG, Czopka T, Ffrench-Constant C, Lyons DA. Individual axons regulate the myelinating potential of single oligodendrocytes in vivo. Development. 2011;138:4443&#x02013;50.<pub-id pub-id-type="pmid">21880787</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Lei</surname><given-names>X</given-names></name><name><surname>Feng</surname><given-names>H</given-names></name><name><surname>Wan</surname><given-names>F</given-names></name><etal/></person-group><article-title>Traditional Chinese Medicine monomers: novel strategy for endogenous neural stem cells activation after stroke</article-title><source>Front Cell Neurosci</source><year>2021</year><volume>15</volume><fpage>628115</fpage><pub-id pub-id-type="doi">10.3389/fncel.2021.628115</pub-id><pub-id pub-id-type="pmid">33716673</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Wang J, Hu J, Chen X, Lei X, Feng H, Wan F, et al. Traditional Chinese Medicine monomers: novel strategy for endogenous neural stem cells activation after stroke. Front Cell Neurosci. 2021;15:628115.<pub-id pub-id-type="pmid">33716673</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Long</surname><given-names>Q</given-names></name><name><surname>Ding</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Progress in the treatment of central nervous system diseases based on nanosized traditional Chinese medicine</article-title><source>Adv Sci</source><year>2024</year><volume>11</volume><fpage>e2308677</fpage><pub-id pub-id-type="doi">10.1002/advs.202308677</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Li J, Long Q, Ding H, Wang Y, Luo D, Li Z, et al. Progress in the treatment of central nervous system diseases based on nanosized traditional Chinese medicine. Adv Sci. 2024;11:e2308677.</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>L</given-names></name><name><surname>Pei</surname><given-names>H</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>C</given-names></name><name><surname>Guan</surname><given-names>Q</given-names></name></person-group><article-title>Paeoniflorin suppresses neuronal ferroptosis to improve the cognitive behaviors in Alzheimer&#x02019;s disease mice</article-title><source>Phytother Res</source><year>2023</year><volume>37</volume><fpage>4791</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1002/ptr.7946</pub-id><pub-id pub-id-type="pmid">37448137</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Zhai L, Pei H, Shen H, Yang Y, Han C, Guan Q. Paeoniflorin suppresses neuronal ferroptosis to improve the cognitive behaviors in Alzheimer&#x02019;s disease mice. Phytother Res. 2023;37:4791&#x02013;800.<pub-id pub-id-type="pmid">37448137</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YX</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>DS</given-names></name><name><surname>Chen</surname><given-names>TT</given-names></name><name><surname>Qi</surname><given-names>XL</given-names></name><name><surname>Tao</surname><given-names>L</given-names></name><etal/></person-group><article-title>Gastrodin alleviates mitochondrial dysfunction by regulating SIRT3-mediated TFAM acetylation in vascular dementia</article-title><source>Phytomedicine</source><year>2024</year><volume>128</volume><fpage>155369</fpage><pub-id pub-id-type="doi">10.1016/j.phymed.2024.155369</pub-id><pub-id pub-id-type="pmid">38547618</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Chen YX, Yang H, Wang DS, Chen TT, Qi XL, Tao L, et al. Gastrodin alleviates mitochondrial dysfunction by regulating SIRT3-mediated TFAM acetylation in vascular dementia. Phytomedicine. 2024;128:155369.<pub-id pub-id-type="pmid">38547618</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Tao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name></person-group><article-title>Natural compounds as potential therapeutic candidates for multiple sclerosis: Emerging preclinical evidence</article-title><source>Phytomedicine</source><year>2024</year><volume>123</volume><fpage>155248</fpage><pub-id pub-id-type="doi">10.1016/j.phymed.2023.155248</pub-id><pub-id pub-id-type="pmid">38096716</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Yuan J, Tao Y, Wang M, Huang F, Wu X. Natural compounds as potential therapeutic candidates for multiple sclerosis: Emerging preclinical evidence. Phytomedicine. 2024;123:155248.<pub-id pub-id-type="pmid">38096716</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Shu</surname><given-names>W</given-names></name></person-group><article-title>Effectiveness of Traditional Chinese Medicine (TCM) treatments on the cognitive functioning of elderly persons with mild cognitive impairment associated with white matter lesions</article-title><source>Shanghai Arch Psychiatry</source><year>2015</year><volume>27</volume><fpage>289</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">26977126</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">He S, Li L, Hu J, Chen Q, Shu W. Effectiveness of Traditional Chinese Medicine (TCM) treatments on the cognitive functioning of elderly persons with mild cognitive impairment associated with white matter lesions. Shanghai Arch Psychiatry. 2015;27:289&#x02013;95.<pub-id pub-id-type="pmid">26977126</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Qiao</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>He</surname><given-names>X</given-names></name><etal/></person-group><article-title>Network topology and machine learning analyses reveal microstructural white matter changes underlying Chinese medicine Dengzhan Shengmai treatment on patients with vascular cognitive impairment</article-title><source>Pharmacol Res</source><year>2020</year><volume>156</volume><fpage>104773</fpage><pub-id pub-id-type="doi">10.1016/j.phrs.2020.104773</pub-id><pub-id pub-id-type="pmid">32244028</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Lu H, Zhang J, Liang Y, Qiao Y, Yang C, He X, et al. Network topology and machine learning analyses reveal microstructural white matter changes underlying Chinese medicine Dengzhan Shengmai treatment on patients with vascular cognitive impairment. Pharmacol Res. 2020;156:104773.<pub-id pub-id-type="pmid">32244028</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>HH</given-names></name><name><surname>Zhang</surname><given-names>FR</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>FF</given-names></name><name><surname>Hou</surname><given-names>JL</given-names></name><name><surname>Wang</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Xinshubao tablet rescues cognitive dysfunction in a mouse model of vascular dementia: Involvement of neurogenesis and neuroinflammation</article-title><source>Biomed Pharmacother</source><year>2024</year><volume>172</volume><fpage>116219</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2024.116219</pub-id><pub-id pub-id-type="pmid">38310654</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Xiao HH, Zhang FR, Li S, Guo FF, Hou JL, Wang SC, et al. Xinshubao tablet rescues cognitive dysfunction in a mouse model of vascular dementia: Involvement of neurogenesis and neuroinflammation. Biomed Pharmacother. 2024;172:116219.<pub-id pub-id-type="pmid">38310654</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>D-J</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Du</surname><given-names>J-L</given-names></name><name><surname>Wang</surname><given-names>Y-W</given-names></name></person-group><article-title>General anesthetics protects against cardiac arrest-induced brain injury by inhibiting calcium wave propagation in zebrafish</article-title><source>Mol Brain</source><year>2017</year><volume>10</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1186/s13041-017-0323-x</pub-id><pub-id pub-id-type="pmid">28052764</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Xu DJ, Wang B, Zhao X, Zheng Y, Du JL, Wang YW. General anesthetics protects against cardiac arrest-induced brain injury by inhibiting calcium wave propagation in zebrafish. Mol Brain. 2017;10:1&#x02013;9.<pub-id pub-id-type="pmid">28052764</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000e4;berlein</surname><given-names>F</given-names></name><name><surname>Mingardo</surname><given-names>E</given-names></name><name><surname>Merten</surname><given-names>N</given-names></name><name><surname>K&#x000f6;hling</surname><given-names>N-KS</given-names></name><name><surname>Reino&#x000df;</surname><given-names>P</given-names></name><name><surname>Simon</surname><given-names>K</given-names></name><etal/></person-group><article-title>Humanized zebrafish as a tractable tool for in vivo evaluation of pro-myelinating drugs</article-title><source>Cell Chem Biol</source><year>2022</year><volume>29</volume><fpage>1541</fpage><lpage>55.e7</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2022.08.007</pub-id><pub-id pub-id-type="pmid">36126653</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">H&#x000e4;berlein F, Mingardo E, Merten N, K&#x000f6;hling N-KS, Reino&#x000df; P, Simon K, et al. Humanized zebrafish as a tractable tool for in vivo evaluation of pro-myelinating drugs. Cell Chem Biol. 2022;29:1541&#x02013;55.e7.<pub-id pub-id-type="pmid">36126653</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Du</surname><given-names>JL</given-names></name><name><surname>He</surname><given-names>C</given-names></name></person-group><article-title>Developmental pruning of early-stage myelin segments during CNS myelination in vivo</article-title><source>Cell Res</source><year>2013</year><volume>23</volume><fpage>962</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1038/cr.2013.62</pub-id><pub-id pub-id-type="pmid">23649315</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Liu P, Du JL, He C. Developmental pruning of early-stage myelin segments during CNS myelination in vivo. Cell Res. 2013;23:962&#x02013;4.<pub-id pub-id-type="pmid">23649315</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Xia</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Hoi</surname><given-names>KK</given-names></name><etal/></person-group><article-title>Oligodendroglial ring finger protein Rnf43 is an essential injury-specific regulator of oligodendrocyte maturation</article-title><source>Neuron</source><year>2021</year><volume>109</volume><fpage>3104</fpage><lpage>18.e6</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2021.07.018</pub-id><pub-id pub-id-type="pmid">34390652</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Niu J, Yu G, Wang X, Xia W, Wang Y, Hoi KK, et al. Oligodendroglial ring finger protein Rnf43 is an essential injury-specific regulator of oligodendrocyte maturation. Neuron. 2021;109:3104&#x02013;18.e6.<pub-id pub-id-type="pmid">34390652</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Tan</surname><given-names>W</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><etal/></person-group><article-title>MSX3 switches microglia polarization and protects from inflammation-induced demyelination</article-title><source>J Neurosci</source><year>2015</year><volume>35</volume><fpage>6350</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2468-14.2015</pub-id><pub-id pub-id-type="pmid">25904788</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Yu Z, Sun D, Feng J, Tan W, Fang X, Zhao M, et al. MSX3 switches microglia polarization and protects from inflammation-induced demyelination. J Neurosci. 2015;35:6350&#x02013;65.<pub-id pub-id-type="pmid">25904788</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Xie</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Gastrodin regulates the TLR4/TRAF6/NF-kappaB pathway to reduce neuroinflammation and microglial activation in an AD model</article-title><source>Phytomedicine</source><year>2024</year><volume>128</volume><fpage>155518</fpage><pub-id pub-id-type="doi">10.1016/j.phymed.2024.155518</pub-id><pub-id pub-id-type="pmid">38552431</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Wang W, Wang Y, Wang F, Xie G, Liu S, Li Z, et al. Gastrodin regulates the TLR4/TRAF6/NF-kappaB pathway to reduce neuroinflammation and microglial activation in an AD model. Phytomedicine. 2024;128:155518.<pub-id pub-id-type="pmid">38552431</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Gastrodin improves the activity of the ubiquitin-proteasome system and the autophagy-lysosome pathway to degrade mutant Huntingtin</article-title><source>Int J Mol Sci</source><year>2024</year><volume>25</volume><fpage>7709</fpage><pub-id pub-id-type="doi">10.3390/ijms25147709</pub-id><pub-id pub-id-type="pmid">39062952</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Sun H, Li M, Li Y, Zheng N, Li J, Li X, et al. Gastrodin improves the activity of the ubiquitin-proteasome system and the autophagy-lysosome pathway to degrade mutant Huntingtin. Int J Mol Sci. 2024;25:7709.<pub-id pub-id-type="pmid">39062952</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Pu</surname><given-names>Y</given-names></name><name><surname>Shao</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Lnc RNA GAS 5 inhibits microglial M2 polarization and exacerbates demyelination</article-title><source>EMBO Rep</source><year>2017</year><volume>18</volume><fpage>1801</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.15252/embr.201643668</pub-id><pub-id pub-id-type="pmid">28808113</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Sun D, Yu Z, Fang X, Liu M, Pu Y, Shao Q, et al. Lnc RNA GAS 5 inhibits microglial M2 polarization and exacerbates demyelination. EMBO Rep. 2017;18:1801&#x02013;16.<pub-id pub-id-type="pmid">28808113</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Parthasarathy</surname><given-names>G</given-names></name><name><surname>Philipp</surname><given-names>MT</given-names></name></person-group><article-title>Receptor tyrosine kinases play a significant role in human oligodendrocyte inflammation and cell death associated with the Lyme disease bacterium Borrelia burgdorferi</article-title><source>J Neuroinflammation</source><year>2017</year><volume>14</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1186/s12974-017-0883-9</pub-id><pub-id pub-id-type="pmid">28086917</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Parthasarathy G, Philipp MT. Receptor tyrosine kinases play a significant role in human oligodendrocyte inflammation and cell death associated with the Lyme disease bacterium Borrelia burgdorferi. J Neuroinflammation. 2017;14:1&#x02013;11.<pub-id pub-id-type="pmid">28086917</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Shao</surname><given-names>Q</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Pu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Nanoparticulate MgH2 ameliorates anxiety/depression-like behaviors in a mouse model of multiple sclerosis by regulating microglial polarization and oxidative stress</article-title><source>J Neuroinflammation</source><year>2023</year><volume>20</volume><fpage>16</fpage><pub-id pub-id-type="doi">10.1186/s12974-023-02696-y</pub-id><pub-id pub-id-type="pmid">36710351</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Li Z, Chen K, Shao Q, Lu H, Zhang X, Pu Y, et al. Nanoparticulate MgH2 ameliorates anxiety/depression-like behaviors in a mouse model of multiple sclerosis by regulating microglial polarization and oxidative stress. J Neuroinflammation. 2023;20:16.<pub-id pub-id-type="pmid">36710351</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Trott</surname><given-names>O</given-names></name><name><surname>Olson</surname><given-names>AJ</given-names></name></person-group><article-title>AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</article-title><source>J Comput Chem</source><year>2010</year><volume>31</volume><fpage>455</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1002/jcc.21334</pub-id><pub-id pub-id-type="pmid">19499576</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455&#x02013;61.<pub-id pub-id-type="pmid">19499576</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Eberhardt</surname><given-names>J</given-names></name><name><surname>Santos-Martins</surname><given-names>D</given-names></name><name><surname>Tillack</surname><given-names>AF</given-names></name><name><surname>Forli</surname><given-names>S</given-names></name></person-group><article-title>AutoDock Vina 1.2. 0: New docking methods, expanded force field, and python bindings</article-title><source>J Chem Inf Model</source><year>2021</year><volume>61</volume><fpage>3891</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1021/acs.jcim.1c00203</pub-id><pub-id pub-id-type="pmid">34278794</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2. 0: New docking methods, expanded force field, and python bindings. J Chem Inf Model. 2021;61:3891&#x02013;8.<pub-id pub-id-type="pmid">34278794</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="other">Shaw D. Desmond molecular dynamics system, version 2022.1. New York, NY: DE Shaw Research; 2022.</mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="other">Bowers KJ, Chow E, Xu H, Dror RO, Eastwood MP, Gregersen BA, et al. Scalable algorithms for molecular dynamics simulations on commodity clusters. In: Proceedings of the 2006 ACM/IEEE Conference on Supercomputing. IEEE, 2006; p. 84-es.</mixed-citation></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>JL</given-names></name><name><surname>Ni</surname><given-names>J</given-names></name><name><surname>You</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Gentisic acid prevents the development of atherosclerotic lesions by inhibiting SNX10-mediated stabilization of LRP6</article-title><source>Pharmacol Res</source><year>2024</year><volume>210</volume><fpage>107516</fpage><pub-id pub-id-type="doi">10.1016/j.phrs.2024.107516</pub-id><pub-id pub-id-type="pmid">39603572</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Chen T, Wang Y, Yang JL, Ni J, You K, Li X, et al. Gentisic acid prevents the development of atherosclerotic lesions by inhibiting SNX10-mediated stabilization of LRP6. Pharmacol Res. 2024;210:107516.<pub-id pub-id-type="pmid">39603572</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Dong</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Zuo</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Screening and identification of peptidyl arginine deiminase 4 inhibitors from herbal plants extracts and purified natural products by a trypsin assisted sensitive immunoassay based on streptavidin magnetic beads</article-title><source>Talanta</source><year>2024</year><volume>279</volume><fpage>126611</fpage><pub-id pub-id-type="doi">10.1016/j.talanta.2024.126611</pub-id><pub-id pub-id-type="pmid">39067202</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Zhao J, Zhang S, Dong J, Chen X, Zuo H, Li Y, et al. Screening and identification of peptidyl arginine deiminase 4 inhibitors from herbal plants extracts and purified natural products by a trypsin assisted sensitive immunoassay based on streptavidin magnetic beads. Talanta. 2024;279:126611.<pub-id pub-id-type="pmid">39067202</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Dong</surname><given-names>C</given-names></name><name><surname>Frah</surname><given-names>M</given-names></name><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Marie</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><etal/></person-group><article-title>Dual requirement of CHD8 for chromatin landscape establishment and histone methyltransferase recruitment to promote CNS myelination and repair</article-title><source>Dev Cell</source><year>2018</year><volume>45</volume><fpage>753</fpage><lpage>68.e8</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2018.05.022</pub-id><pub-id pub-id-type="pmid">29920279</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Zhao C, Dong C, Frah M, Deng Y, Marie C, Zhang F, et al. Dual requirement of CHD8 for chromatin landscape establishment and histone methyltransferase recruitment to promote CNS myelination and repair. Dev Cell. 2018;45:753&#x02013;68.e8.<pub-id pub-id-type="pmid">29920279</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>B</given-names></name><name><surname>Baror</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Segel</surname><given-names>M</given-names></name><name><surname>Dietmann</surname><given-names>S</given-names></name><name><surname>Rawji</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Metformin restores CNS remyelination capacity by rejuvenating aged stem cells</article-title><source>Cell Stem Cell</source><year>2019</year><volume>25</volume><fpage>473</fpage><lpage>85.e8</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2019.08.015</pub-id><pub-id pub-id-type="pmid">31585093</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Neumann B, Baror R, Zhao C, Segel M, Dietmann S, Rawji KS, et al. Metformin restores CNS remyelination capacity by rejuvenating aged stem cells. Cell Stem Cell. 2019;25:473&#x02013;85.e8.<pub-id pub-id-type="pmid">31585093</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Metformin attenuates white matter injury and cognitive impairment induced by chronic cerebral hypoperfusion</article-title><source>J Cereb Blood Flow Metab</source><year>2023</year><volume>43</volume><fpage>78</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1177/0271678X231175189</pub-id><pub-id pub-id-type="pmid">37177813</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">He Y, Li Z, Shi X, Ding J, Wang X. Metformin attenuates white matter injury and cognitive impairment induced by chronic cerebral hypoperfusion. J Cereb Blood Flow Metab. 2023;43:78&#x02013;94.<pub-id pub-id-type="pmid">37177813</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>J</given-names></name><name><surname>Mei</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Mo</surname><given-names>W</given-names></name><etal/></person-group><article-title>Phosphorylated olig1 localizes to the cytosol of oligodendrocytes and promotes membrane expansion and maturation</article-title><source>Glia</source><year>2012</year><volume>60</volume><fpage>1427</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1002/glia.22364</pub-id><pub-id pub-id-type="pmid">22639060</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Niu J, Mei F, Wang L, Liu S, Tian Y, Mo W, et al. Phosphorylated olig1 localizes to the cytosol of oligodendrocytes and promotes membrane expansion and maturation. Glia. 2012;60:1427&#x02013;36.<pub-id pub-id-type="pmid">22639060</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Deshmukh</surname><given-names>VA</given-names></name><name><surname>Tardif</surname><given-names>V</given-names></name><name><surname>Lyssiotis</surname><given-names>CA</given-names></name><name><surname>Green</surname><given-names>CC</given-names></name><name><surname>Kerman</surname><given-names>B</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>A regenerative approach to the treatment of multiple sclerosis</article-title><source>Nature</source><year>2013</year><volume>502</volume><fpage>327</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1038/nature12647</pub-id><pub-id pub-id-type="pmid">24107995</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Deshmukh VA, Tardif V, Lyssiotis CA, Green CC, Kerman B, Kim HJ, et al. A regenerative approach to the treatment of multiple sclerosis. Nature. 2013;502:327&#x02013;32.<pub-id pub-id-type="pmid">24107995</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Emery</surname><given-names>B</given-names></name><name><surname>Wood</surname><given-names>TL</given-names></name></person-group><article-title>Regulators of oligodendrocyte differentiation</article-title><source>Cold Spring Harb Perspect Biol</source><year>2024</year><volume>16</volume><fpage>041358</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a041358</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Emery B, Wood TL. Regulators of oligodendrocyte differentiation. Cold Spring Harb Perspect Biol. 2024;16:041358.</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Franklin</surname><given-names>RJ</given-names></name></person-group><article-title>Why does remyelination fail in multiple sclerosis?</article-title><source>Nat Rev Neurosci</source><year>2002</year><volume>3</volume><fpage>705</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1038/nrn917</pub-id><pub-id pub-id-type="pmid">12209119</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Franklin RJ. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci. 2002;3:705&#x02013;14.<pub-id pub-id-type="pmid">12209119</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>JJ</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Zhou</surname><given-names>XY</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Gastrodin ameliorates the lipopolysaccharide-induced neuroinflammation in mice by downregulating miR-107-3p</article-title><source>Front Pharmacol</source><year>2022</year><volume>13</volume><fpage>1044375</fpage><pub-id pub-id-type="doi">10.3389/fphar.2022.1044375</pub-id><pub-id pub-id-type="pmid">36569291</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Song JJ, Li H, Wang N, Zhou XY, Liu Y, Zhang Z, et al. Gastrodin ameliorates the lipopolysaccharide-induced neuroinflammation in mice by downregulating miR-107-3p. Front Pharmacol. 2022;13:1044375.<pub-id pub-id-type="pmid">36569291</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Dedoni</surname><given-names>S</given-names></name><name><surname>Scherma</surname><given-names>M</given-names></name><name><surname>Camoglio</surname><given-names>C</given-names></name><name><surname>Siddi</surname><given-names>C</given-names></name><name><surname>Dazzi</surname><given-names>L</given-names></name><name><surname>Puliga</surname><given-names>R</given-names></name><etal/></person-group><article-title>An overall view of the most common experimental models for multiple sclerosis</article-title><source>Neurobiol Dis</source><year>2023</year><volume>184</volume><fpage>106230</fpage><pub-id pub-id-type="doi">10.1016/j.nbd.2023.106230</pub-id><pub-id pub-id-type="pmid">37453561</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Dedoni S, Scherma M, Camoglio C, Siddi C, Dazzi L, Puliga R, et al. An overall view of the most common experimental models for multiple sclerosis. Neurobiol Dis. 2023;184:106230.<pub-id pub-id-type="pmid">37453561</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Nocera</surname><given-names>S</given-names></name><name><surname>Chan</surname><given-names>JR</given-names></name></person-group><article-title>Remyelination by preexisting oligodendrocytes: glass half full or half empty?</article-title><source>Neuron</source><year>2023</year><volume>111</volume><fpage>1689</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2023.05.001</pub-id><pub-id pub-id-type="pmid">37290399</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Nocera S, Chan JR. Remyelination by preexisting oligodendrocytes: glass half full or half empty? Neuron. 2023;111:1689&#x02013;91.<pub-id pub-id-type="pmid">37290399</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez Juarez</surname><given-names>A</given-names></name><name><surname>He</surname><given-names>D</given-names></name><name><surname>Richard Lu</surname><given-names>Q</given-names></name></person-group><article-title>Oligodendrocyte progenitor programming and reprogramming: Toward myelin regeneration</article-title><source>Brain Res</source><year>2016</year><volume>1638</volume><fpage>209</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2015.10.051</pub-id><pub-id pub-id-type="pmid">26546966</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Lopez Juarez A, He D, Richard Lu Q. Oligodendrocyte progenitor programming and reprogramming: Toward myelin regeneration. Brain Res. 2016;1638:209&#x02013;20.<pub-id pub-id-type="pmid">26546966</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Cadavid</surname><given-names>D</given-names></name><name><surname>Mellion</surname><given-names>M</given-names></name><name><surname>Hupperts</surname><given-names>R</given-names></name><name><surname>Edwards</surname><given-names>KR</given-names></name><name><surname>Calabresi</surname><given-names>PA</given-names></name><name><surname>Drulovic</surname><given-names>J</given-names></name><etal/></person-group><article-title>Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial</article-title><source>Lancet Neurol</source><year>2019</year><volume>18</volume><fpage>845</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(19)30137-1</pub-id><pub-id pub-id-type="pmid">31285147</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Cadavid D, Mellion M, Hupperts R, Edwards KR, Calabresi PA, Drulovic J, et al. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2019;18:845&#x02013;56.<pub-id pub-id-type="pmid">31285147</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>JWL</given-names></name><name><surname>Cunniffe</surname><given-names>NG</given-names></name><name><surname>Prados</surname><given-names>F</given-names></name><name><surname>Kanber</surname><given-names>B</given-names></name><name><surname>Jones</surname><given-names>JL</given-names></name><name><surname>Needham</surname><given-names>E</given-names></name><etal/></person-group><article-title>Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study</article-title><source>Lancet Neurol</source><year>2021</year><volume>20</volume><fpage>709</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(21)00179-4</pub-id><pub-id pub-id-type="pmid">34418398</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Brown JWL, Cunniffe NG, Prados F, Kanber B, Jones JL, Needham E, et al. Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study. Lancet Neurol. 2021;20:709&#x02013;20.<pub-id pub-id-type="pmid">34418398</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="other">Balashov K. Drugs in development for multiple sclerosis. Practical Neurol. 2020:40&#x02013;3.</mixed-citation></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Jakel</surname><given-names>S</given-names></name><name><surname>Agirre</surname><given-names>E</given-names></name><name><surname>Mendanha Falcao</surname><given-names>A</given-names></name><name><surname>van Bruggen</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>KW</given-names></name><name><surname>Knuesel</surname><given-names>I</given-names></name><etal/></person-group><article-title>Altered human oligodendrocyte heterogeneity in multiple sclerosis</article-title><source>Nature</source><year>2019</year><volume>566</volume><fpage>543</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-0903-2</pub-id><pub-id pub-id-type="pmid">30747918</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Jakel S, Agirre E, Mendanha Falcao A, van Bruggen D, Lee KW, Knuesel I, et al. Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature. 2019;566:543&#x02013;7.<pub-id pub-id-type="pmid">30747918</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Mezydlo</surname><given-names>A</given-names></name><name><surname>Treiber</surname><given-names>N</given-names></name><name><surname>Ullrich Gavilanes</surname><given-names>EM</given-names></name><name><surname>Eichenseer</surname><given-names>K</given-names></name><name><surname>Ancau</surname><given-names>M</given-names></name><name><surname>Wens</surname><given-names>A</given-names></name><etal/></person-group><article-title>Remyelination by surviving oligodendrocytes is inefficient in the inflamed mammalian cortex</article-title><source>Neuron</source><year>2023</year><volume>111</volume><fpage>1748</fpage><lpage>59.e8</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2023.03.031</pub-id><pub-id pub-id-type="pmid">37071991</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Mezydlo A, Treiber N, Ullrich Gavilanes EM, Eichenseer K, Ancau M, Wens A, et al. Remyelination by surviving oligodendrocytes is inefficient in the inflamed mammalian cortex. Neuron. 2023;111:1748&#x02013;59.e8.<pub-id pub-id-type="pmid">37071991</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Poskanzer</surname><given-names>KE</given-names></name><name><surname>Freeman</surname><given-names>MR</given-names></name><name><surname>Monk</surname><given-names>KR</given-names></name></person-group><article-title>Live-imaging of astrocyte morphogenesis and function in zebrafish neural circuits</article-title><source>Nat Neurosci</source><year>2020</year><volume>23</volume><fpage>1297</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1038/s41593-020-0703-x</pub-id><pub-id pub-id-type="pmid">32895565</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Chen J, Poskanzer KE, Freeman MR, Monk KR. Live-imaging of astrocyte morphogenesis and function in zebrafish neural circuits. Nat Neurosci. 2020;23:1297&#x02013;306.<pub-id pub-id-type="pmid">32895565</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>KL</given-names></name><name><surname>Grant</surname><given-names>NJ</given-names></name><name><surname>Temperley</surname><given-names>ND</given-names></name><name><surname>Patton</surname><given-names>EE</given-names></name></person-group><article-title>Small molecule screening in zebrafish: an in vivo approach to identifying new chemical tools and drug leads</article-title><source>Cell Commun Signal</source><year>2010</year><volume>8</volume><fpage>11</fpage><pub-id pub-id-type="doi">10.1186/1478-811X-8-11</pub-id><pub-id pub-id-type="pmid">20540792</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Taylor KL, Grant NJ, Temperley ND, Patton EE. Small molecule screening in zebrafish: an in vivo approach to identifying new chemical tools and drug leads. Cell Commun Signal. 2010;8:11.<pub-id pub-id-type="pmid">20540792</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Early</surname><given-names>JJ</given-names></name><name><surname>Cole</surname><given-names>KL</given-names></name><name><surname>Williamson</surname><given-names>JM</given-names></name><name><surname>Swire</surname><given-names>M</given-names></name><name><surname>Kamadurai</surname><given-names>H</given-names></name><name><surname>Muskavitch</surname><given-names>M</given-names></name><etal/></person-group><article-title>An automated high-resolution in vivo screen in zebrafish to identify chemical regulators of myelination</article-title><source>Elife</source><year>2018</year><volume>7</volume><fpage>e35136</fpage><pub-id pub-id-type="doi">10.7554/eLife.35136</pub-id><pub-id pub-id-type="pmid">29979149</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Early JJ, Cole KL, Williamson JM, Swire M, Kamadurai H, Muskavitch M, et al. An automated high-resolution in vivo screen in zebrafish to identify chemical regulators of myelination. Elife. 2018;7:e35136.<pub-id pub-id-type="pmid">29979149</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>M</given-names></name><name><surname>Meng</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Cai</surname><given-names>P</given-names></name><etal/></person-group><article-title>A review on central nervous system effects of gastrodin</article-title><source>Front Pharmacol</source><year>2018</year><volume>9</volume><fpage>24</fpage><pub-id pub-id-type="doi">10.3389/fphar.2018.00024</pub-id><pub-id pub-id-type="pmid">29456504</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Liu Y, Gao J, Peng M, Meng H, Ma H, Cai P, et al. A review on central nervous system effects of gastrodin. Front Pharmacol. 2018;9:24.<pub-id pub-id-type="pmid">29456504</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>G</given-names></name><name><surname>Tang</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title>Review on pharmacological effects of gastrodin</article-title><source>Arch Pharm Res</source><year>2023</year><volume>46</volume><fpage>744</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1007/s12272-023-01463-0</pub-id><pub-id pub-id-type="pmid">37749449</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Xiao G, Tang R, Yang N, Chen Y. Review on pharmacological effects of gastrodin. Arch Pharm Res. 2023;46:744&#x02013;70.<pub-id pub-id-type="pmid">37749449</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>JN</given-names></name><name><surname>Zong</surname><given-names>Y</given-names></name><name><surname>Zhong</surname><given-names>LM</given-names></name><name><surname>Li</surname><given-names>YM</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Bian</surname><given-names>LG</given-names></name><etal/></person-group><article-title>Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e21891</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0021891</pub-id><pub-id pub-id-type="pmid">21765922</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Dai JN, Zong Y, Zhong LM, Li YM, Zhang W, Bian LG, et al. Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways. PLoS One. 2011;6:e21891.<pub-id pub-id-type="pmid">21765922</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname><given-names>M</given-names></name><name><surname>Yin</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><etal/></person-group><article-title>Effect of the SSeCKS-TRAF6 interaction on gastrodin-mediated protection against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced astrocyte activation and neuronal death</article-title><source>Chemosphere</source><year>2019</year><volume>226</volume><fpage>678</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.chemosphere.2019.04.003</pub-id><pub-id pub-id-type="pmid">30959452</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Jiao M, Yin K, Zhang T, Wu C, Zhang Y, Zhao X, et al. Effect of the SSeCKS-TRAF6 interaction on gastrodin-mediated protection against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced astrocyte activation and neuronal death. Chemosphere. 2019;226:678&#x02013;86.<pub-id pub-id-type="pmid">30959452</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Fang</surname><given-names>S</given-names></name><name><surname>Lv</surname><given-names>G</given-names></name><name><surname>Mei</surname><given-names>X</given-names></name></person-group><article-title>Gastrodin promotes the secretion of brain-derived neurotrophic factor in the injured spinal cord</article-title><source>Neural Regen Res</source><year>2013</year><volume>8</volume><fpage>1383</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">25206433</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Song C, Fang S, Lv G, Mei X. Gastrodin promotes the secretion of brain-derived neurotrophic factor in the injured spinal cord. Neural Regen Res. 2013;8:1383&#x02013;9.<pub-id pub-id-type="pmid">25206433</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Xiao</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Gastrodin promotes CNS myelination via a lncRNA Gm7237/miR-142a/MRF pathway</article-title><source>RNA Biol</source><year>2021</year><volume>18</volume><fpage>1279</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1080/15476286.2020.1841976</pub-id><pub-id pub-id-type="pmid">33151124</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Shu Y, Luo T, Wang M, Zhang Y, Zhang L, Xiao Z, et al. Gastrodin promotes CNS myelination via a lncRNA Gm7237/miR-142a/MRF pathway. RNA Biol. 2021;18:1279&#x02013;90.<pub-id pub-id-type="pmid">33151124</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Gastrodin modified polyurethane conduit promotes nerve repair via optimizing Schwann cells function</article-title><source>Bioact Mater</source><year>2022</year><volume>8</volume><fpage>355</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">34541406</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Yang H, Li Q, Li L, Chen S, Zhao Y, Hu Y, et al. Gastrodin modified polyurethane conduit promotes nerve repair via optimizing Schwann cells function. Bioact Mater. 2022;8:355&#x02013;67.<pub-id pub-id-type="pmid">34541406</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Gaesser</surname><given-names>JM</given-names></name><name><surname>Fyffe-Maricich</surname><given-names>SL</given-names></name></person-group><article-title>Intracellular signaling pathway regulation of myelination and remyelination in the CNS</article-title><source>Exp Neurol</source><year>2016</year><volume>283</volume><fpage>501</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2016.03.008</pub-id><pub-id pub-id-type="pmid">26957369</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Gaesser JM, Fyffe-Maricich SL. Intracellular signaling pathway regulation of myelination and remyelination in the CNS. Exp Neurol. 2016;283:501&#x02013;11.<pub-id pub-id-type="pmid">26957369</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Figlia</surname><given-names>G</given-names></name><name><surname>Gerber</surname><given-names>D</given-names></name><name><surname>Suter</surname><given-names>U</given-names></name></person-group><article-title>Myelination and mTOR</article-title><source>Glia</source><year>2018</year><volume>66</volume><fpage>693</fpage><lpage>707</lpage><pub-id pub-id-type="doi">10.1002/glia.23273</pub-id><pub-id pub-id-type="pmid">29210103</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Figlia G, Gerber D, Suter U. Myelination and mTOR. Glia. 2018;66:693&#x02013;707.<pub-id pub-id-type="pmid">29210103</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname><given-names>HJ</given-names></name><name><surname>Wang</surname><given-names>PX</given-names></name><name><surname>Ren</surname><given-names>XQ</given-names></name><name><surname>Shi</surname><given-names>HL</given-names></name><name><surname>Shi</surname><given-names>JS</given-names></name><name><surname>Guo</surname><given-names>T</given-names></name><etal/></person-group><article-title>Gastrodin regulates PI3K/AKT-Sirt3 signaling pathway and proinflammatory mediators in activated microglia</article-title><source>Mol Neurobiol</source><year>2024</year><volume>61</volume><fpage>2728</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1007/s12035-023-03743-8</pub-id><pub-id pub-id-type="pmid">37930585</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Zuo HJ, Wang PX, Ren XQ, Shi HL, Shi JS, Guo T, et al. Gastrodin regulates PI3K/AKT-Sirt3 signaling pathway and proinflammatory mediators in activated microglia. Mol Neurobiol. 2024;61:2728&#x02013;44.<pub-id pub-id-type="pmid">37930585</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>XS</given-names></name><name><surname>Tian</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>HL</given-names></name><name><surname>Zhao</surname><given-names>MG</given-names></name><etal/></person-group><article-title>Protective effects of gastrodin against autophagy-mediated astrocyte death</article-title><source>Phytother Res</source><year>2016</year><volume>30</volume><fpage>386</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1002/ptr.5538</pub-id><pub-id pub-id-type="pmid">26643508</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Wang XS, Tian Z, Zhang N, Han J, Guo HL, Zhao MG, et al. Protective effects of gastrodin against autophagy-mediated astrocyte death. Phytother Res. 2016;30:386&#x02013;96.<pub-id pub-id-type="pmid">26643508</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name></person-group><article-title>Proliferation-enhancing effects of gastrodin on RSC96 Schwann cells by regulating ERK1/2 and PI3K signaling pathways</article-title><source>Biomed Pharmacother</source><year>2016</year><volume>84</volume><fpage>747</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2016.09.106</pub-id><pub-id pub-id-type="pmid">27710899</pub-id>
</element-citation><mixed-citation id="mc-CR70" publication-type="journal">Zuo W, Xu F, Zhang K, Zheng L, Zhao J. Proliferation-enhancing effects of gastrodin on RSC96 Schwann cells by regulating ERK1/2 and PI3K signaling pathways. Biomed Pharmacother. 2016;84:747&#x02013;53.<pub-id pub-id-type="pmid">27710899</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>K</given-names></name><etal/></person-group><article-title>Gastrodin protects retinal ganglion cells from ischemic injury by activating phosphatidylinositol 3-kinase/protein kinase B/nuclear factor erythroid 2-related factor 2 (PI3K/AKT/Nrf2) signaling pathway</article-title><source>Bioengineered</source><year>2022</year><volume>13</volume><fpage>12625</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1080/21655979.2022.2076499</pub-id><pub-id pub-id-type="pmid">35609324</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">Li S, Yang Q, Zhou Z, Yang X, Liu Y, Hao K, et al. Gastrodin protects retinal ganglion cells from ischemic injury by activating phosphatidylinositol 3-kinase/protein kinase B/nuclear factor erythroid 2-related factor 2 (PI3K/AKT/Nrf2) signaling pathway. Bioengineered. 2022;13:12625&#x02013;36.<pub-id pub-id-type="pmid">35609324</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>EM</given-names></name><name><surname>Purger</surname><given-names>D</given-names></name><name><surname>Mount</surname><given-names>CW</given-names></name><name><surname>Goldstein</surname><given-names>AK</given-names></name><name><surname>Lin</surname><given-names>GL</given-names></name><name><surname>Wood</surname><given-names>LS</given-names></name><etal/></person-group><article-title>Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain</article-title><source>Science</source><year>2014</year><volume>344</volume><fpage>1252304</fpage><pub-id pub-id-type="doi">10.1126/science.1252304</pub-id><pub-id pub-id-type="pmid">24727982</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Gibson EM, Purger D, Mount CW, Goldstein AK, Lin GL, Wood LS, et al. Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science. 2014;344:1252304.<pub-id pub-id-type="pmid">24727982</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz</surname><given-names>FC</given-names></name><name><surname>Habermacher</surname><given-names>C</given-names></name><name><surname>Graciarena</surname><given-names>M</given-names></name><name><surname>Houry</surname><given-names>PY</given-names></name><name><surname>Nishiyama</surname><given-names>A</given-names></name><name><surname>Nait Oumesmar</surname><given-names>B</given-names></name><etal/></person-group><article-title>Neuronal activity in vivo enhances functional myelin repair</article-title><source>JCI Insight</source><year>2019</year><volume>5</volume><fpage>e123434</fpage><pub-id pub-id-type="doi">10.1172/jci.insight.123434</pub-id><pub-id pub-id-type="pmid">30896448</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Ortiz FC, Habermacher C, Graciarena M, Houry PY, Nishiyama A, Nait Oumesmar B, et al. Neuronal activity in vivo enhances functional myelin repair. JCI Insight. 2019;5:e123434.<pub-id pub-id-type="pmid">30896448</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>S</given-names></name><name><surname>Shu</surname><given-names>S</given-names></name><name><surname>Zhai</surname><given-names>L</given-names></name><name><surname>Xia</surname><given-names>S</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><etal/></person-group><article-title>Optogenetic stimulation of mPFC alleviates white matter injury-related cognitive decline after chronic ischemia through adaptive myelination</article-title><source>Adv Sci</source><year>2023</year><volume>10</volume><fpage>e2202976</fpage><pub-id pub-id-type="doi">10.1002/advs.202202976</pub-id></element-citation><mixed-citation id="mc-CR74" publication-type="journal">Deng S, Shu S, Zhai L, Xia S, Cao X, Li H, et al. Optogenetic stimulation of mPFC alleviates white matter injury-related cognitive decline after chronic ischemia through adaptive myelination. Adv Sci. 2023;10:e2202976.</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Rawji</surname><given-names>KS</given-names></name><name><surname>Young</surname><given-names>AMH</given-names></name><name><surname>Ghosh</surname><given-names>T</given-names></name><name><surname>Michaels</surname><given-names>NJ</given-names></name><name><surname>Mirzaei</surname><given-names>R</given-names></name><name><surname>Kappen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system</article-title><source>Acta Neuropathol</source><year>2020</year><volume>139</volume><fpage>893</fpage><lpage>909</lpage><pub-id pub-id-type="doi">10.1007/s00401-020-02129-7</pub-id><pub-id pub-id-type="pmid">32030468</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Rawji KS, Young AMH, Ghosh T, Michaels NJ, Mirzaei R, Kappen J, et al. Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system. Acta Neuropathol. 2020;139:893&#x02013;909.<pub-id pub-id-type="pmid">32030468</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Berghoff</surname><given-names>SA</given-names></name><name><surname>Spieth</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>T</given-names></name><name><surname>Hosang</surname><given-names>L</given-names></name><name><surname>Schlaphoff</surname><given-names>L</given-names></name><name><surname>Depp</surname><given-names>C</given-names></name><etal/></person-group><article-title>Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis</article-title><source>Nat Neurosci</source><year>2021</year><volume>24</volume><fpage>47</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1038/s41593-020-00757-6</pub-id><pub-id pub-id-type="pmid">33349711</pub-id>
</element-citation><mixed-citation id="mc-CR76" publication-type="journal">Berghoff SA, Spieth L, Sun T, Hosang L, Schlaphoff L, Depp C, et al. Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis. Nat Neurosci. 2021;24:47&#x02013;60.<pub-id pub-id-type="pmid">33349711</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Su</surname><given-names>D</given-names></name><name><surname>Xiao</surname><given-names>C</given-names></name><etal/></person-group><article-title>Gastrodin programs an Arg-1<sup>+</sup> microglial phenotype in hippocampus to ameliorate depression- and anxiety-like behaviors via the Nrf2 pathway in mice</article-title><source>Phytomedicine</source><year>2023</year><volume>113</volume><fpage>154725</fpage><pub-id pub-id-type="doi">10.1016/j.phymed.2023.154725</pub-id><pub-id pub-id-type="pmid">36867963</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Zhang J, Li L, Liu Q, Zhao Z, Su D, Xiao C, et al. Gastrodin programs an Arg-1<sup>+</sup> microglial phenotype in hippocampus to ameliorate depression- and anxiety-like behaviors via the Nrf2 pathway in mice. Phytomedicine. 2023;113:154725.<pub-id pub-id-type="pmid">36867963</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Qu</surname><given-names>M</given-names></name></person-group><article-title>Gastrodin attenuates pentylenetetrazole-induced seizures by modulating the mitogen-activated protein kinase-associated inflammatory responses in mice</article-title><source>Neurosci Bull</source><year>2017</year><volume>33</volume><fpage>264</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1007/s12264-016-0084-z</pub-id><pub-id pub-id-type="pmid">27909971</pub-id>
</element-citation><mixed-citation id="mc-CR78" publication-type="journal">Chen L, Liu X, Wang H, Qu M. Gastrodin attenuates pentylenetetrazole-induced seizures by modulating the mitogen-activated protein kinase-associated inflammatory responses in mice. Neurosci Bull. 2017;33:264&#x02013;72.<pub-id pub-id-type="pmid">27909971</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><name><surname>Xin</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Effect of gastrodin on early brain injury and neurological outcome after subarachnoid hemorrhage in rats</article-title><source>Neurosci Bull</source><year>2019</year><volume>35</volume><fpage>461</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1007/s12264-018-00333-w</pub-id><pub-id pub-id-type="pmid">30673960</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Wang X, Li S, Ma J, Wang C, Chen A, Xin Z, et al. Effect of gastrodin on early brain injury and neurological outcome after subarachnoid hemorrhage in rats. Neurosci Bull. 2019;35:461&#x02013;70.<pub-id pub-id-type="pmid">30673960</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>